JPS62907B2 - - Google Patents
Info
- Publication number
- JPS62907B2 JPS62907B2 JP54012883A JP1288379A JPS62907B2 JP S62907 B2 JPS62907 B2 JP S62907B2 JP 54012883 A JP54012883 A JP 54012883A JP 1288379 A JP1288379 A JP 1288379A JP S62907 B2 JPS62907 B2 JP S62907B2
- Authority
- JP
- Japan
- Prior art keywords
- product
- group
- compound
- formula
- cyclobutylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000047 product Substances 0.000 claims description 57
- 150000001875 compounds Chemical class 0.000 claims description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 26
- -1 cyanogen halide Chemical class 0.000 claims description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 14
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims description 12
- 239000011541 reaction mixture Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- KHYDCTMLGIZSEH-JQHSSLGASA-N 7,8-didehydro-3-methoxy-17-methylmorphinan-6-one Chemical compound C1C(=O)C=C[C@H]2[C@]3([H])N(C)CC[C@@]21C1=CC(OC)=CC=C1C3 KHYDCTMLGIZSEH-JQHSSLGASA-N 0.000 claims description 8
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- LQCYIQBYFCQMCH-UHFFFAOYSA-N [Li].C[Cu]C Chemical compound [Li].C[Cu]C LQCYIQBYFCQMCH-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- 239000002516 radical scavenger Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- SETCBEYYECBQHR-UHFFFAOYSA-N [Li].CCC[Cu]CCC Chemical compound [Li].CCC[Cu]CCC SETCBEYYECBQHR-UHFFFAOYSA-N 0.000 claims description 6
- 239000002168 alkylating agent Substances 0.000 claims description 6
- 229940100198 alkylating agent Drugs 0.000 claims description 6
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- OMYYOIIFAWKWGG-UHFFFAOYSA-N [Li].CC[Cu]CC Chemical compound [Li].CC[Cu]CC OMYYOIIFAWKWGG-UHFFFAOYSA-N 0.000 claims description 5
- 150000003868 ammonium compounds Chemical class 0.000 claims description 5
- 239000012298 atmosphere Substances 0.000 claims description 5
- FLHFTXCMKFVKRP-UHFFFAOYSA-N bromomethylcyclobutane Chemical compound BrCC1CCC1 FLHFTXCMKFVKRP-UHFFFAOYSA-N 0.000 claims description 5
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 claims description 5
- 239000003495 polar organic solvent Substances 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 4
- 150000008282 halocarbons Chemical class 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 230000017858 demethylation Effects 0.000 claims description 2
- 238000010520 demethylation reaction Methods 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 2
- 238000007259 addition reaction Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 19
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000000921 elemental analysis Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 12
- 238000007792 addition Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000725 suspension Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000000147 hypnotic effect Effects 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- 150000003840 hydrochlorides Chemical class 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960005181 morphine Drugs 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000003042 antagnostic effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 239000012458 free base Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- NNUUOAQJUHMLDS-NNWRFLSQSA-N (1S,9R,10R)-17-(cyclobutylmethyl)-4-methoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one Chemical compound C([C@@]12C3=CC(OC)=CC=C3C[C@@]3([C@@H]1CCC(=O)C2)[H])CN3CC1CCC1 NNUUOAQJUHMLDS-NNWRFLSQSA-N 0.000 description 3
- WDOGXJOKAKESFR-RPSVNGOUSA-N (1S,9R,10R,11S)-17-(cyclobutylmethyl)-4-hydroxy-11-propyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one hydrochloride Chemical compound Cl.C([C@@]12C3=CC(O)=CC=C3C[C@@]3([C@@H]1[C@@H](CCC)CC(=O)C2)[H])CN3CC1CCC1 WDOGXJOKAKESFR-RPSVNGOUSA-N 0.000 description 3
- KGNCYOLPIOFVSQ-XAUMKULISA-N 3-methoxymorphinan-6-one hydrochloride Chemical compound Cl.C1C(=O)CC[C@H]2[C@]3([H])NCC[C@@]21C1=CC(OC)=CC=C1C3 KGNCYOLPIOFVSQ-XAUMKULISA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RPRKLSZTTTUWSR-JUFSGVNBSA-N (1S,9R,10R)-17-(cyclobutylmethyl)-4-hydroxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one hydrochloride Chemical compound Cl.C([C@@]12C3=CC(O)=CC=C3C[C@@]3([C@@H]1CCC(=O)C2)[H])CN3CC1CCC1 RPRKLSZTTTUWSR-JUFSGVNBSA-N 0.000 description 2
- XUSCOHKHRDQKCI-ARFHVFGLSA-N (1S,9R,10R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2,4,6-trien-13-one Chemical class C1C(=O)CC[C@H]2[C@]3([H])NCC[C@@]21C1=CC=CC=C1C3 XUSCOHKHRDQKCI-ARFHVFGLSA-N 0.000 description 2
- KTEZBBASLLXKMF-MSPPYGBUSA-N (1S,9R,10R,11S)-17-(cyclobutylmethyl)-11-ethyl-4-methoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one hydrochloride Chemical compound Cl.C([C@@]12CC(=O)C[C@@H]([C@H]2[C@H]2CC=3C1=CC(OC)=CC=3)CC)CN2CC1CCC1 KTEZBBASLLXKMF-MSPPYGBUSA-N 0.000 description 2
- IEQZKXFFHDKCPH-JQHSSLGASA-N 17-cyano-3-methoxymorphinan-6-one Chemical compound C1C(=O)CC[C@H]2[C@]3([H])N(C#N)CC[C@@]21C1=CC(OC)=CC=C1C3 IEQZKXFFHDKCPH-JQHSSLGASA-N 0.000 description 2
- CRRWFNHEPSGMEN-MBBGPGJISA-N 17-cyclobutylmethyl-3-hydroxy-8β-methylmorphinan-6-one hydrochloride Chemical compound Cl.C([C@@]12CC(=O)C[C@@H]([C@H]2[C@H]2CC=3C1=CC(O)=CC=3)C)CN2CC1CCC1 CRRWFNHEPSGMEN-MBBGPGJISA-N 0.000 description 2
- REOQNPWHSFWKET-KPSHGPNUSA-N 17-cyclobutylmethyl-3-methoxy-8β-methylmorphinan-6-one hydrochloride Chemical compound Cl.C([C@]12CC(=O)C[C@H](C)[C@H]1[C@H]1CC3=CC=C(C=C32)OC)CN1CC1CCC1 REOQNPWHSFWKET-KPSHGPNUSA-N 0.000 description 2
- NHHVLJQPGAAVEL-JUFSGVNBSA-N 17-cyclopropylmethyl-3-methoxymorphinan-6-one hydrochloride Chemical compound Cl.C([C@@]12C3=CC(OC)=CC=C3C[C@@]3([C@@H]1CCC(=O)C2)[H])CN3CC1CC1 NHHVLJQPGAAVEL-JUFSGVNBSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- FCJHDGUWJDXJKI-JQHSSLGASA-N 3-methoxy-17-methylmorphinan-6-one Chemical compound C1C(=O)CC[C@H]2[C@]3([H])N(C)CC[C@@]21C1=CC(OC)=CC=C1C3 FCJHDGUWJDXJKI-JQHSSLGASA-N 0.000 description 2
- PIVIRHJKPCKFPD-BUTJSCNGSA-N 3-methoxy-8β-methylmorphinan-6-one hydrochloride Chemical compound Cl.C1C(=O)C[C@H](C)[C@H]2[C@H]3CC4=CC=C(OC)C=C4[C@]21CCN3 PIVIRHJKPCKFPD-BUTJSCNGSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- GFZHKWGREZBWQT-ITGOXPRASA-N chembl2311138 Chemical compound C([C@]12CC(=O)C[C@H](C)[C@H]1[C@H]1CC3=CC=C(C=C32)OC)CN1CC1CC1 GFZHKWGREZBWQT-ITGOXPRASA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- XBEREOHJDYAKDA-UHFFFAOYSA-N lithium;propane Chemical compound [Li+].CC[CH2-] XBEREOHJDYAKDA-UHFFFAOYSA-N 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical group C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical compound C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003892 tartrate salts Chemical class 0.000 description 2
- ANMXYNZJTJHYGX-LXZKKBNFSA-N (1S,9R,10R)-6-hydroxy-4-methoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one Chemical class C1C(=O)CC[C@H]2[C@]3([H])NCC[C@@]21C1=CC(OC)=CC(O)=C1C3 ANMXYNZJTJHYGX-LXZKKBNFSA-N 0.000 description 1
- DGXMHZUCZGMMKA-GVDBMIGSSA-N (1S,9R,10R)-6-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2,4,6-trien-13-one Chemical compound C1C(=O)CC[C@H]2[C@]3([H])NCC[C@@]21C1=CC=CC(C)=C1C3 DGXMHZUCZGMMKA-GVDBMIGSSA-N 0.000 description 1
- RNRUYOINBWXVPY-SCDHXWHXSA-N (1S,9R,10R,11S)-4-methoxy-11-propyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one hydrochloride Chemical compound Cl.C1C2=CC=C(OC)C=C2[C@]23CC(=O)C[C@H](CCC)[C@H]3[C@@H]1NCC2 RNRUYOINBWXVPY-SCDHXWHXSA-N 0.000 description 1
- PZHCMXMGHSQUJV-JHQYFNNDSA-N 17-cyano-3-methoxy-8β-methylmorphinan-6-one Chemical compound C[C@H]([C@H]12)CC(=O)C[C@@]11CCN(C#N)[C@@H]2CC2=CC=C(OC)C=C21 PZHCMXMGHSQUJV-JHQYFNNDSA-N 0.000 description 1
- PDELVBUIQOGXRW-PSMQTCRGSA-N 17-cyano-3-methoxy-8β-n-propylmorphinan-6-one Chemical compound C1C(=O)C[C@H](CCC)[C@H]2[C@]3([H])N(C#N)CC[C@@]21C1=CC(OC)=CC=C1C3 PDELVBUIQOGXRW-PSMQTCRGSA-N 0.000 description 1
- VDSHRIABCYXDCJ-RNAPXVLBSA-N 17-cyclobutylmethyl-3-methoxy-8β-methyl-morphinan-6-one Chemical compound C([C@]12CC(=O)C[C@H](C)[C@H]1[C@H]1CC3=CC=C(C=C32)OC)CN1CC1CCC1 VDSHRIABCYXDCJ-RNAPXVLBSA-N 0.000 description 1
- JMRCYEFEEQSEKU-PSMQTCRGSA-N 3-methoxy-17-methyl-8β-n-propylmorphinan-6-one Chemical compound C1C(=O)C[C@H](CCC)[C@H]2[C@]3([H])N(C)CC[C@@]21C1=CC(OC)=CC=C1C3 JMRCYEFEEQSEKU-PSMQTCRGSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- JWTUKQUXWFYBJS-GVDBMIGSSA-N chembl1254108 Chemical compound C1C(=O)CC[C@H]2[C@]3([H])N(C)CC[C@@]21C1=CC=CC=C1C3 JWTUKQUXWFYBJS-GVDBMIGSSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 description 1
- WPBXOELOQKLBDF-UHFFFAOYSA-N cyanogen iodide Chemical compound IC#N WPBXOELOQKLBDF-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001335 demethylating effect Effects 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- BLHLJVCOVBYQQS-UHFFFAOYSA-N ethyllithium Chemical compound [Li]CC BLHLJVCOVBYQQS-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940068938 morphine injection Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00Â -Â C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00Â -Â C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00Â -Â C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00Â -Â C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Description
ããç¥ãããå¬ç æ§é®çã¢ã«ãã€ã³ã¯æ¬¡ã®åºæ¬
çç°æ§é ãæããŠããã é žçŽ æ¶æ©ãååšããªããšãããã®ç°ç³»ã¯ã次ã®
æ§é åŒ ãæããã¢ã«ãã€ãã³ç³»ãšåŒã°ãããåŒäžãççŽ
ååã®çªå·ããã³ç°æå®ã¯è¡šç€ºãããšããã§ã
ãã ã¢ã«ãã€ã³ããã³ãã®é¡çžäœã¯ãäž»ãšããŠãç
ã¿ã®è§£é€ã®ããã«çšããããïŒé®çïŒããããã¯
å¬ç æ§ã§ããããããŠãã®æ®ãã©ã®ãã®ã¯åŸå±ç
èªçºèœãæããŠãããäžã€çæ³çé®çå€ä»¥äžã®ã
ã®ãšããŠããä»ã®å¯äœçšãçã¥ãïŒååã䟿ç§ã
çºæ±ãåŒåžäœäžãç³åçž®å°ïŒã é®çïŒåç矀ïŒããã³å¬ç æ§æ®æäœçšã®é©åãª
茪éãæã€ååç©ã¯ãè¬ç©äŸåæ§ãããã¯è¬ç©åŒ
害ã®æ¬ é¥ç¡ãããŠãæ¿ããçã¿ãæå¶ããé®çå€
ãšããŠã®å¯èœæ§ãæãããã®ã§ããã ããã«èšèŒããé®çå¬ç æ®æå€ã®åºçºç©è³ªãšã
ãŠçšããããïŒïŒïŒâãžããããâïŒâã¡ããã·
â17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã¯ããµã¯ã
ãã³ããšãã«ãã€ãŠå ±åãããŠãããããã©ãã
ãã³ïŒTetrahedronïŒ20ïŒ2247ïŒ1964ïŒã以äž
âãµã¯âãšãããã ç±³åœç¹èš±3654280ïŒãµã¯ããå¡©é矩補è¬(æ ª)ã
1972ïŒïŒïŒïŒçºè¡ã以äžâå¡©é矩âãšããïŒã«
ã¯ãâãµã¯âã«ãã€ãŠå ±åãããååç©ã«é¢ä¿ã
ãããçš®ã®17âã¢ãªã«ã17âãžã¡ãã«ã¢ãªã«åã¯
17âã·ã¯ããããã«ã¡ãã«çœ®æïŒâããããã·â
ã¢ã«ãã€ãã³âïŒâãªã³ååç©ã®å¬ç æ§æ®æ掻æ§
ãå ±åãããŠããã ããããã·ã«åºåã¯ãšãŒãã«åºã®åŠãïŒâäœã
é žçŽ ååã§çœ®æãããã¢ã«ãã€ãã³âïŒâãªã³å
åç©ã¯ãã¿ããã«ãã€ãŠå ±åãããŠãããããã©
ãããã³ã¬ã¿ãŒãºïŒTetr.Lett.ïŒ1805ïŒ1960ïŒãã
ã»ããã±ãã«ã«ãã¢ãŒãã·ãŠãŒãã€ã«ã«ãã¬ã¿ã³
ïŒChem.Pharm.Bull.ïŒ14ïŒ445ïŒ1966ïŒãã¯ãïŒäœ
ããããªãžãã«åºã«ãã眮æãããããªãã·ãã
ã©ãããã³ãã€ã³ååç©ãå ±åããŠããã æ¬çºæã®äž»é¡ã«ã¯æ¬¡ã®ãã®ãå«ãŸããã (a) äžèšæ§é åŒã åŒäžãR1ã¯æ°ŽçŽ åååã¯ã¡ãã«åºã§ããã äœããR1ãæ°ŽçŽ ååã§ãããšãR2ã¯ã·ã¯ã
ããã«ã¡ãã«ã§ããã R2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯ããã
ã«ã¡ãã«åºã§ããã R3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«åºã§
ãããäœããR3ããšãã«åã¯ïœâãããã«ã§
ãããšãR1ã¯æ°ŽçŽ ååã§ããã ãæããååç©ããã³è¬çåŠçã«æŽ»æ§ãªãã®é ž
ä»å å¡©ã (b) äžèš(a)ã«ç€ºããæ§é ã®ååç©ã®æ²»çåŠçã«æ
å¹éããã®çš®ã®æ²»çãå¿ èŠãšããã人ã«æäž
ãããã®äººã«ç¡çèŠçãçããããæ²»çæ¹æ³ã (c) R1ãã¡ãã«åºã§ãããR2ãã·ã¯ããããã«
ã¡ãã«åã¯ã·ã¯ãããã«ã¡ãã«ã§ããããããŠ
R3ãã¡ãã«ããšãã«åã¯ïœâãããã«ã§ãã
æ§é åŒãæããååç©ããäžèšå·¥çšã«ãã補
é ããæ¹æ³ã (i) ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ããããã²ã³
åçåæ°ŽçŽ åã¯è³éŠæçåæ°ŽçŽ æº¶åªäžã§ããª
ããŠã ãžãšãã«é ããªããŠã ãžã¡ãã«é ãã
ã³ãªããŠã ãžâïœâãããã«é ãããªã矀ã
ãéžã°ãããªããŠã ãžææ©é è©Šè¬ãšå ±åœ¹ïŒïŒ
ïŒâä»å åå¿ã«ããåå¿ãããã (ii) ãã®åå¿æ··åç©ãã¢ã³ã¢ããŠã ååç©ã®æ°Ž
溶液ãšéãã«åå¿ãããïŒâã¢ã«ãã«åçæ
ç©ã補é ãã (iii) ãã®ïŒâã¢ã«ãã«åçæç©ãã·ã¢ãã²ã³ã
ã©ã€ããšåå¿ããããŠãïŒâã¢ã«ãã«å17â
ã·ã¢ãçæç©ã補é ãã (iv) ãã®ïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ãé±
é žã§å æ°Žå解ããŠãïŒâã¢ã«ãã«å17âãã«
çæç©ã補é ããããã³ (v) ãã®ïŒâã¢ã«ãã«å17âãã«çæç©ããã·
ã¯ããããã«ã¡ãã«ãããã€ãããã³ã·ã¯ã
ããã«ã¡ãã«ãããã€ããããªã矀ããéžã°
ããã¢ã«ãã«åå€ãšé žææå€ã®ååšäžã«åå¿
ãããŠãææãšãã(a)ã®ïŒâã¢ã«ãã«åâ
眮æååç©ãåŸãã (d) äžèš(c)ã®ååç©ããéæµæž©åºŠã«ãããŠå æ°Žå
解å€ã«ããè±ã¡ãã«åããããšãããªãR1ã
æ°ŽçŽ ã§ããäžèš(c)ã«ãããŠåŸãããæ§é ãæã
ãååç©ã補é ããæ¹æ³ã (e) äžèšæ§é åŒã åŒäžãR4ã¯æ°ŽçŽ ãã¡ãã«ãã·ã¢ãåã¯ã·ã¯
ãããã«ã¡ãã«åºãR5ã¯ã¡ãã«ããšãã«åã¯
ïœâãããã«åºãäœããR4ãæ°ŽçŽ ãã¡ãã«å
ã¯ã·ã¢ãã®ãšãã®ã¿R5ã¯ã¡ãã«ã§ããã ãæããååç©ãå å«ãããäžèš(a)ã®æ§é ãæ
ããååç©ã®è£œé ã«ããããæçšãªäžéäœã äžèšåŒã®ååç©ã¯ãïŒâäœã«ã¢ã«ãã«çœ®æåº
ãæã€æ°èŠãªç¹åŸŽãæããã¢ã«ãã€ãã³âïŒâãª
ã³ååç©ã®å æ¬çååç©çŸ€ãè¡šãããŠããã åŒäžãR1ã¯æ°ŽçŽ åååã¯ã¡ãã«åºãäœãã
R1ãæ°ŽçŽ ååã§ãããšãR2ã¯ã·ã¯ãããã«ã¡ã
ã«ã§ããïŒR2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯
ãããã«ã¡ãã«åºã§ããïŒR3ã¯ã¡ãã«ããšãã«
ããã³ïœâãããã«åºãããªã矀ããéžã°ãã
åºãäœããR3ããšãã«åã¯ïœâãããã«åºã§ã
ããšãR1ã¯æ°ŽçŽ ååã§ããã åŒäžãããã³åœ¢ã®ç·ïŒãïŒã¯èšèŒãããŠãã
ããã«çŽé¢ã®äžæ¹ã«çªãåºãŠãã眮æåºã瀺ããŠ
ããããããŠãβâæ¹äœãšåŒã°ããã åŒã®ïŒâ眮æã¢ã«ãã€ãã³âïŒâãªã³ååç©
ã¯ãææ©åã¯ç¡æ©é žã«ãã€ãŠè¬çåŠçã«æŽ»æ§ãªé ž
ä»å å¡©ã圢æãããé žä»å å¡©ã®äŸãšããŠã¯ãé ç³
é žå¡©ãå¡©é žå¡©ãèåæ°ŽçŽ é žå¡©ããã¬ã€ã³é žå¡©çã§
ããã奜ãŸããå¡©ã¯å¡©é žå¡©ã§ããã æ¬çºæè ã¯ãçš®ã 眮æãããïŒâã¡ããã·ïŒã
ãããã·ïŒã¢ã«ãã€ãã³âïŒâãªã³ã®ïŒäœã«äœçŽ
ã¢ã«ãã«åºãå°å ¥ãããšãæå€ã«ããïŒäœæ°ŽçŽ ã®
åã¿ã€ãã®ååç©ã«ã¯èŠãããªãå¬ç æ§æ®æ掻æ§
ãäžããããšãèŠãåºããã æ¬çºæã®ååç©ã¯ããã®çš®ã®æ²»çãèŠæ±ããã
å人ã®çã¿ã®åŠçœ®ã®ããã«æçšã§ãããâå人â
ãšã¯ã人éåã¯äººéã®ã¢ãã«ãšãªãå®éšåç©ãæ
å³ããŠããã æå¹éã¯å人ãå人ã«ãã€ãŠç°ãªãããé床ã®
å®éšãããªããšãåœæ¥è ã«ãã容æã«æ±ºå®ãã
ããååç©ã¯ãé泚ãéçµå£ãããã«ã«ãçŽè ž
åã¯å£è ã®åŠãå ¬ç¥æ £çšã®æ²»çæäžæ¹æ³ã«ãã€ãŠ
æäžããããšãã§ãããååç©ã®æäžåœ¢æ ã¯ã
補è¬ç§åŠã§èªç¥ãããæ¹æ³ã«ãã€ãŠè£œé ããããš
ãã§ããã R2ãã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯ãããã«
ã¡ãã«ã§ãããR3ãã¡ãã«ããšãã«åã¯ïœâã
ããã«ã§ããåŒã®ååç©ã¯ãâãµã¯âã«ãã€ãŠ
èšèŒãããããã«ããŠè£œé ãããå ¬ç¥ã®ååç©ã
ïŒïŒïŒâãžããããâïŒâã¡ããã·â17âã¡ãã«
ã¢ã«ãã€ãã³âïŒâãªã³ããªãã¡æåã®åºçºç©è³ª
ã ãããªããŠã ãžã¡ãã«é ããªããŠã ãžãšãã«é å
ã¯ãªããŠã ãžâïœâãããã«é ã®åŠããªããŠã ãž
ææ©é ãšïŒïŒïŒâä»å ã«ããåå¿ããããããšã«
ããåæããããïŒïŒïŒâä»å ã«ããããªããŠã
ãžææ©é ã®äœ¿çšã¯ããã¹ããŒïŒPosnerïŒã«ãã
èšèŒãããŠããããªãŒã¬ããã¯ãªã¢ã¯ã·ãšã³ãº
ïŒOrg.ReactionsïŒ19ïŒïŒïŒ1972ïŒãã ããããªããããã¹ããŒã¯ã¢ã«ãã€ãã³ç³»ã«ã
ãããã®çš®ã®åå¿ã®äœ¿çšã«ã€ããŠã¯æ瀺ããŠããª
ãã ãªããŠã ãžææ©é è©Šè¬ã¯ãã¡ãã«ããšãã«åã¯
ïœâãããã«ãªããŠã ã®ïŒã¢ã«åœéãå«ã溶液
ãããšãŒãã«ãããã©ããããã©ã³çã ã®åŠã溶
åªäžã®æ²åé çŽïŒã¢ã«åœéãå«ãæ¹æããããµã³
ãã³ãžãšã³ã«ãçªçŽ åã¯ã¢ã«ãŽã³ã®ç¡æ¹¿æ°é°å²æ°
äžã§æ·»å ããããšã«ãã補é ãããããªããŠã ãž
ã¡ãã«é ã¯ïŒâã§è£œé ããããªããŠã ãžãšãã«é
ããã³ãªããŠã ãžâïœâãããã«é ã¯â78âã§è£œ
é ãããâ40âãŸã§æž©ãŸã€ãŠãè¯ãã ïŒïŒïŒâãžããããâïŒâã¡ããã·â17âã¡ã
ã«ã¢ã«ãã€ãã³âïŒâãªã³ãã®ã¡ãã¬ã³ã¯ãã©
ã€ãããšãã¬ã³ã¯ãã©ã€ãããžã¯ãããšã¿ã³çã
ã®åŠãããã²ã³åçåæ°ŽçŽ æº¶åªåã¯ãã³ãŒã³ãã
ã«ãšã³ããã·ã¬ã³çã ã®åŠãè³éŠæçåæ°ŽçŽ æº¶åª
äžã®æº¶æ¶²ã¯ã奜ãŸããã¯äžæŽ»æ§ãªç¡æ¹¿æ°é°å²æ°äž
ã«ãããŠããªããŠã ãžææ©é ã®æ¹æããããµã¹ã
ã³ãžãšã³ã«æ·»å ããããããŠåå¿ãããçšããã
ãè©Šè¬ããªããŠã ãžã¡ãã«é ã®å Žåã«ã¯ãåå¿æ··
åç©ããååç©ãæ·»å ããŠããéäžïŒâã«ä¿æ
ããã®ã奜ãŸããããããŠããã®æ··åç©ã¯çŽïŒæ
éè¿æ¹æããããçšããããè©Šè¬ããªããŠã ãžãš
ãã«é åã¯ãªããŠã ãžâïœâãããã«é ã®å Žåã«
ã¯ãåå¿æ··åç©ããååç©ã®æº¶æ¶²ãæ·»å ããŠã
ãéäžããã³çŽ10åéã®åå¿æéã®éäžãçŽâ78
âãâ40âã«ä¿æããã®ãæãŸãããååç©å¯Ÿ
ãªããŠã ãžææ©é è©Šè¬ã®ã¢ã«æ¯ã¯ãïŒïŒïŒãïŒïŒ
ïŒã®ç¯å²ãæãŸããããã®å·¥çšã«ããããã³ãŒã³
ã®äœ¿çšã¯å¥œãŸããã åå¿æ··åç©ã¯ã奜ãŸããã¯çŽïŒâãŸã§æž©ãã
ããããããå¡©åã¢ã³ã¢ã³ãæ°Žé žåã¢ã³ã¢ããŠã
çã ã®åŠãã¢ã³ã¢ããŠã ååç©ã®æ°Žæº¶æ¶²ãšã奜ãŸ
ããã¯ããã®åå¿æ··åç©äžã«å«ãŸããé ã®ã¢ã«é
å°ã®ç¶æ ã§ãéããã«åå¿ãããããã åŸãããæ··åç©ã¯ãïŒæéè¿æ¹æããæ§é åŒ
ãæããïŒâã¢ã«ãã«åçæç©ãçæããã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã åŸãããæ··åç©ã®æ°Žçžãåé¢ãããããŠ50ïŒ æ°Ž
é žåãããªãŠã åã¯æ°Žé žåã«ãªãŠã ã®åŠã匷塩åº
ãæ·»å ããŠçŽPH12ã«èª¿ç¯ããã次ãã§ããã®å¡©åº
æ§æ°Žæº¶æ¶²ããšãŒãã«ãã¯ãããã«ã çã®åŠãé©åœ
ãªææ©æº¶åªã§æœåºããããã®ææ©æœåºç©ã¯æ¬¡ã
ã§ãæŽæµãã也ç¥ããããŠèžçºããæ§é åŒãæ
ããçæç©ãåé¢ããã åé¢ãããçæç©ã¯ããšãŒãã«ãã¯ãããã«
ã çã®åŠãé©åœãªææ©æº¶åªã奜ãŸããã¯ç¡æ°Žçé ž
ã«ãªãŠã åã¯çé žãããªãŠã ã®åŠãé©åœãªé žææ
å€ãå«æãããããã®ææ©æº¶åªã«æº¶è§£ããããã·
ã¢ãã²ã³ãããã€ããã·ã¢ãã²ã³ã¯ãã©ã€ãåã¯
ã·ã¢ãã²ã³ã¢ã€ãªãã€ãã®åŠãã·ã¢ãã²ã³ãã©ã€
ãã®æº¶æ¶²ãã次ãã§ããã®æ··åç©ã«ãã€ãããšæ·»
å ããããã®ãµã¹ãã³ãžãšã³ã¯ã奜ãŸããã¯çŽ20
âã溶åªã®éæµæž©åºŠã§çŽïŒæéãŸã§æ¹æãããæ§
é åŒã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã ãæãã17âã·ã¢ãçæç©ãçæããããã®ãµã¹
ãã³ãžãšã³ã¯ã奜ãŸããã¯ãäžæº¶æ§ç©ã®åé¢ã容
æã«ãããããªæž©åºŠãŸã§å·åŽããã次ãã§ããã®
äžæº¶æ§ç©ã¯éãããã¯é å¿åé¢ã«ããé€å»ã
ãããããŠæº¶åªãèžçºãããŠ17âã·ã¢ãçæç©
ãåé¢ããã ãã®17âã·ã¢ãçæç©ã¯ãå¡©é žãç¡«é žãç¡é ž
çãããã¯å¡©é žã®åŠãã奜ãŸããã¯1Nã6Nã®é±
é žäžã«æžæ¿ããããããŠãçŽïŒæéãŸã§éæµæž©åºŠ
ã«å ç±ãããŠå æ°Žå解ãããæ§é åŒã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã ãæããïŒâã¢ã«ãã«å17âãã«çæç©ãçæã
ããååç©ã¯ã溶åªãèžçºãããããšã«ããå¡©
é žå¡©ãšããŠåå¿æ··åç©ããåé¢ãããã ãã®ïŒâã¢ã«ãã«å17âãã«çæç©åã¯å Žå
ã«ãã€ãŠãã®å¡©é žä»å å¡©ãã次ãã§ã«ãªãŠã åã¯
ãããªãŠã çé žå¡©åã¯éçé žå¡©ã®åŠãé žææå€ã®
ååšäžã§ã·ã¯ããããã«ã¡ãã«ãããã€ãåã¯ã·
ã¯ãããã«ã¡ãã«ãããã€ãã®åŠãã¢ã«ãã«åå€
ãšåå¿ããããïŒâã¢ã«ãã«å17âãã«çæç©
察ã¢ã«ãã«åå€å¯Ÿé žææå€ã®ã¢ã«æ¯ã¯ããã®é åº
ã§ã奜ãŸããã¯ïŒïŒïŒïŒïŒãïŒïŒïŒïŒïŒã®ç¯å²ã§
ãããåå¿ã¯ã奜ãŸããã¯ãçŽ50âã110âã®æž©
床ã§ãçªçŽ åã¯ã¢ã«ãŽã³ã®åŠãäžæŽ»æ§ãªç¡æ¹¿æ°é°
å²æ°äžã«ãããŠããžã¡ãã«ãã«ã ã¢ããããžã¡ã
ã«ã¹ã«ãããµã€ãããšã¿ããŒã«çã ã®åŠã極æ§æ
æ©æº¶åªäžã§è¡ãªããããR1ãã¡ãã«åºã§ããã
R2ããã³R3ãäžèšãšåãã§ããæ§é åŒãæã
ãåå¿çæç©ã¯ã次ãã§ã溶åªæœåºãããã¯ã¯ã
ããã°ã©ãã€ãŒã®åŠãåœè©²åéã®æšæºçæ¹æ³ã«ã
ãåé¢ãããã R1ãæ°ŽçŽ ã§ããæ§é åŒãæããååç©ã¯ã
R1ãã¡ãã«åºã§ããååç©ããããªãžã³å¡©é ž
å¡©ãèåæ°ŽçŽ é žçã®åŠãå æ°Žå解å€ãçšããŠïŒ¯â
è±ã¡ãã«åããããšã«ããã補é ãããéæµæž©åºŠ
ã§çŽ10ã20åéãèåæ°ŽçŽ é žã奜ãŸããã¯çŽ48ïŒ
ã§çšããã®ãæãŸããã 氎溶解æ§ãå¢å€§ããçæç©ãåŸãããšãæãŸã
ãå Žåã«ã¯ãã®ææ©ã®åã¯ç¡æ©ã®é žä»å å¡©ã補
é ããããšãã§ãããè¬çåŠçã«èš±å®¹ãããé žä»
å å¡©ã®äŸã¯ãé ç³é žå¡©ãå¡©é žå¡©ãèåæ°ŽçŽ é žå¡©ã
ãã¬ã€ã³é žå¡©çã ã§ãããå¡©é žå¡©ã¯å¥œãŸãããã®
ã§ãããå¡©é žå¡©ã¯ã奜ãŸããã¯ããšãŒãã«åã¯é ¢
é žãšãã«ã®åŠãææ©æº¶åªã«ãã®éé¢ã®å¡©åºã溶解
ã溶解ããããããŠãããã«ã¬ã¹ç¶ã®å¡©åæ°ŽçŽ ã
å ããããšã«ãã€ãŠåŸãããããã¯äœçŽã¢ã«ã³ãŒ
ã«ã«ãã®éé¢ã®å¡©åºã溶解ãããå¡©é žæ°Žæº¶æ¶²ãæ·»
å ãããããŠæº¶åªãèžçºãããããšã«ãã€ãŠåŸ
ããçŽç²ãªå¡©ã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœ
ãããããŒã«çãå å«ããäœçŽã¢ã«ã³ãŒã«ã®åŠã
溶åªãããããã«é ¢é žã¡ãã«ãé ¢é žãšãã«ãé ¢é ž
ã€ãœãããã«çã®åŠãäœçŽãšã¹ãã«ãå ãã次ã
ã§ã沞ãšããããŠã¢ã«ã³ãŒã«ãé€å»ããåçµæ¶ã«
ããã䟿å©ã«ååŸãããã å®æœäŸ ïŒ 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5119ïŒ ãã®å®æœäŸã¯ãè¡šèšååç©ã®äžéäœã®è£œæ³ãå
å«ããã  ïŒÎ²ïŒ17âãžã¡ãã«âïŒâã¡ããã·ã¢ã«ãã€
ãã³âïŒâãªã³ïŒTR5068ïŒ ãšãŒãã«âãã³ãŒã³äžã«ããã補é ãªããŠã ãžã¡ãã«é ã®æº¶æ¶²ã¯ãã¡ãã«ãªã
ãŠã ïŒ0.159ã¢ã«ããšãŒãã«ã®1.84M溶液86
mlãAlfa Chem.Co.補ïŒãæ²åé ïŒ15.1ïœã
0.0794ã¢ã«ïŒã®ç¡æ°ŽãšãŒãã«ã®ãµã¹ãã³ãžãš
ã³ã«æ·»å ããŠãã¢ã«ãŽã³é°å²æ°äžãïŒâã§è£œ
é ããããã®æº¶æ¶²ã«ãïŒïŒïŒâãžããããâ
ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³âïŒ
âãªã³ïŒ18.0ïœã0.064ã¢ã«ïŒâãµã¯âã«ã
ãèšèŒãããæ¹æ³ã§è£œé ããïŒã®ä¹Ÿç¥ãã³ãŒ
ã³æº¶æ¶²ã滎äžããŠå ãããããŠãåŸãããæ··
åç©ãçŽïŒâã§ïŒæéæ¹æããã次ãã§ãã
ã®æ··åç©ã飜åNH4Cl溶液ïŒ1LïŒã«æ³šå ¥
ãã宀枩ã§çŽ30åéæ¹æãããææ©çžãæ··å
ç©ããåé¢ãããããŠæ°Žçžã50ïŒ NaOH溶液
ãæ·»å ããŠçŽPH12ã«èª¿ç¯ãããåŸãããæ°Žçž
ãã次ãã§ãã¯ãããã«ã ã§ïŒåæœåºããã
ããŠãäžç·ã«ããææ©æœåºç©ã飜åNH4Cl溶
液ã§æŽæµããMgSO4ã§ä¹Ÿç¥ãããããŠèžçº
ããããåŸãããæ®æž£ãé ¢é žãšãã«ã«æº¶è§£
ãããããŠæº¶åªãèžçºããçµæ¶æ®æž£ãåŸãã
ãã®çµæ¶æ®æž£ãã掻æ§çåŠçã®åŸé ¢é žãšãã«
ããåçµæ¶ããã10.0ïœã®TR5068ãmp126
ã127âãåŸããæ¯æ¶²ããæŽã«3.0ïœã®çæç©
ãåŸãããå šåçã¯68ïŒ ã§ãã€ãããšã¿ããŒ
ã«ããã®åçµæ¶ã«ããçŽç²ãªTR5068ã
mp131ã132âãåŸãããã å çŽ åæãèšç®å€ïŒC19H25NO2ïŒïŒïŒ£ïŒ76.22ïŒ
ïŒ8.42ïŒïŒ®ïŒ4.68 å®æž¬å€ïŒïŒ£ïŒ76.16ïŒïŒšïŒ8.35ïŒïŒ®ïŒ4.49 TR5068ã®å¡©é žå¡©ã¯ãéé¢ã®å¡©åºããšã¿ã
ãŒã«ã«æº¶è§£ãããéå°ã®æ¿HClãå ãããã
ãŠæ··åç©ã也ç¥ãããŸã§èžçºãããŠè£œé ã
ããåŸãããæ®æž£ãæŽã«ãå ããšã¿ããŒã«
ã§ã次ãã§ïŒïŒ1VïŒïŒ¶ãšã¿ããŒã«ïŒãã³ãŒ
ã³ã§ããããŠæåŸã«ãã³ãŒã³ã«ããã¢ãŒãªã
ãããã¯æ³ã«ãã也ç¥ãããã也ç¥ããçæ
ç©ããšã¿ããŒã«âé ¢é žãšãã«ããçµæ¶åãã
ããšãTR5068ã»HClãmp274ã276âãäžã
ãã å çŽ åæãèšç®å€ïŒC19H25NO2ã»HClïŒïŒïŒ£ïŒ
67.94ïŒïŒšïŒ7.80ïŒïŒ®ïŒ4.17ïŒClïŒ10.13 å®æž¬å€ïŒïŒ£ïŒ68.35ïŒïŒšïŒ7.38ïŒïŒ®ïŒ4.01ïŒ
ClïŒ10.13 ãšãŒãã«âã¡ãã¬ã³ã¯ãã©ã€ãäžã«ããã
補é å®æœäŸ1Aã«èšèŒããããã«ããŠãã¡ãã«
ãªããŠã ïŒ0.131ã¢ã«ïŒããã³æ²åé ïŒ12.4
ïœã0.066ã¢ã«ïŒãšãã補é ãããªããŠã ãž
ã¡ãã«é ã®æº¶æ¶²ããã¢ã«ãŽã³äžã«ïŒâã§è£œé
ããããã®æº¶æ¶²ã«ãã¡ãã¬ã³ã¯ãã©ã€ã150
mläžã®ïŒïŒïŒâãžããããâïŒâã¡ããã·â
17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒ15.0
ïœã0.053ã¢ã«ããµã¯ã«åŸã€ãŠè£œé ããïŒã®
溶液ã滎äžãããåå¿ããå®æœäŸïŒã®ããã«
ããŠãæŽã«ãåŠçãããã¯ãããã«ã æœåºç©
ã®èžçºã«ããåŸãããæ®æž£ãé ¢é žãšãã«ãã
çµæ¶åãããTR5068 9.70ïœãåŸãïŒåç61
ïŒ ïŒã  17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ 1.5ïœã®åŸ®ç²åãã也ç¥K2CO3ãå«ãã¯ãã
ãã«ã äžã®ïŒÎ²ïŒ17âãžã¡ãã«âïŒâã¡ããã·
âã¢ã«ãã€ãã³âïŒâãªã³ïŒéé¢å¡©åºïŒäžèšïŒ¡
ã§è£œé ãããã®ïŒã®ã¯ãããã«ã äžã®æ··åç©
ïŒ1.0ïœïŒ10mlïŒãæ¥éã«æ¹æããããã«ã¯ãã
ãã«ã äžã®ã·ã¢ãã²ã³ãããã€ã溶液ïŒ1.2åœ
éïŒ1.0ïœïŒ20mlïŒãããã€ãããšæ»Žäžããã
ãã®æ··åç©ã30åéæ¥éã«æ¹æãã次ãã§ãæŽ
ã«ïŒæééæµäžã«å ç±ããã溶液ãå·åŽãã
éãã也ç¥ãããŸã§èžçºãããããŠãã¢ã«ã³ãŒ
ã«ã§å ±æ²žä¹Ÿç¥ãããm.p.202ã205âã®çµæ¶ç
æç©ã81ïŒ ã®åçã§åŸãããããã®ãã®ã¯ãæŽ
ã«ç²Ÿè£œããããšãªãã«ã䜿çšãããã  ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³â
ïŒâãªã³å¡©é žå¡© 2NâHCläžã®17âã·ã¢ãâïŒâã¡ããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¢ã§
補é ãããã®ïŒã®ãµã¹ãã³ãžãšã³ïŒïŒïœïŒ30
mlïŒãïŒæééæµãããåŸããã溶液ã也ç¥ã
ããŸã§èžçºããããšã¿ããŒã«ã§æ°åºŠã«ãããå ±
沞也ç¥ããããããŠããšã¿ããŒã«äžã«æžæ¿ãã
çµæ¶æ§æ®æž£ãæéããããã®çæç©ã¯ãæŽã«ç²Ÿ
補ããããšãªãã«ã䜿çšããããçµæ¶æ§ç©ã
m.p.204ã208âãã®åçã¯90ïŒ ã§ãã€ãã  17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·â
ïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5119ïŒ DMFäžã®ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«
ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒäžèšïŒ£ã§è£œé ãã
ãã®ïŒã®ãµã¹ãã³ãžãšã³ïŒïŒïœïŒ10mlïŒã«
NaHCO3ïŒ2.2åœéïŒeq.ïŒïŒããã³ã·ã¯ããã
ãã«ã¡ãã«ãããã€ãïŒ1.5eq.ïŒãšãå ããã
ãã®æ··åç©ããã¢ã«ãŽã³é°å²æ°äžã100âã§16
æéå ç±ãã次ãã§å·åŽãããæ··åç©ãé
ãã液ãé«æžå§äžã§èžçºãããæ®æž£ãåŸãã
æ®æž£ãæ°Žã«æº¶è§£ããæ¿NH4OHã§PHçŽ11ã«èª¿ç¯
ãããã³ãŒã³ã§ïŒåæœåºãããææ©çžã也ç¥
ããéãããããŠèžçºã«ããæ®æž£ãšãããã
ã®æ®æž£ãã15ïŒïŒïŒïŒ¶ïŒïŒ¶ïŒã¯ãããã«ã ïŒã¡
ã¿ããŒã«ãå±éå€ãšããŠçšããã·ãªã«ã²ã«ïŒ§ã«
ããã¯ãããã°ã©ããããçŽç²Ÿãªã¯ãããã°ã©
ãã®ãã©ã¯ã·ãšã³ãäžç·ã«ãããçæç©ã¯éé¢
å¡©åºãm.p.114ã115âããšããŠ72ïŒ ã®åçã§
çµæ¶ãšããŠåŸãããã å çŽ åæïŒèšç®å€ïŒC22H29NO2ïŒïŒïŒ£ïŒ77.84ïŒ
ïŒ8.61ïŒïŒ®ïŒ4.13 å®æž¬å€ïŒïŒ£ïŒ77.75ïŒïŒšïŒ8.33ïŒïŒ®ïŒ4.00 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒÎ²
âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5132ïŒ ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒ
âãªã³å¡©é žå¡©ïŒäžèš1Cã§è£œé ãããã®ïŒã®è©Šæ
ããã·ã¯ããããã«ã¡ãã«ãããã€ããã·ã¯ãã
ãã«ã¡ãã«ãããã€ãïŒ1.5eq.ïŒã«æããä»ã¯å®
æœäŸ1Dã«ããããšåæ§ã«ããŠãåŠçãããçæ
ç©ãå®æœäŸ1Dã«ããããšåæ§ã«ããŠåé¢ããã
ããŠãå¡©é žå¡©ã«å€æãããåç34ïŒ ãm.p.217ã
220âã å çŽ åæãèšç®å€ïŒC23H31NO2ã»HClïŒïŒïŒ£ïŒ
70.84ïŒïŒšïŒ8.27ïŒïŒ®ïŒ3.59ïŒClïŒ9.50 å®æž¬å€ïŒïŒ£ïŒ70.47ïŒïŒšïŒ8.19ïŒïŒ®ïŒ3.48ïŒ
ClïŒ9.23 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5130ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒÎ²
âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒå®æœäŸïŒã§è£œ
é ãããã®ïŒããã³48ïŒ HBr氎溶液ïŒå€«ã ã1.0
ïœïŒïŒmlïŒã®è©Šæãã140âã«äºãå ç±ãã油济
äžã§20åééæµããããæ··åç©ãæ°·äžã§å·åŽãã
30mlã®æ°Žã§åžéããããã®æ°Žæº¶æ¶²ããæ¿NH4OH
ãå ããããšã«ãããPHçŽ11ã«èª¿ç¯ããããã®å¡©
åºæ§æ··åç©ãã¯ãããã«ã ã§ïŒåæœåºãããã
ãŠããã®ææ©æœåºç©ãå®æœäŸ1Dã«ããããšåæ§
ã«åŠçãããæ®æž£ãå®æœäŸ1Dã«ããããšåæ§ã«
ããŠã·ãªã«ã²ã«ïŒ§ã®ã¯ãããã°ã©ãã«ãããçæ
ç©ãå¡©é žå¡©ãšããŠåé¢ãããåç84ïŒ ãmp150â
ïŒçºæ³¡ã䌎ã€ãŠå解ïŒã å çŽ åæãèšç®å€ïŒC22H29NO2ã»HClïŒïŒïŒ£ïŒ
70.29ïŒïŒšïŒ8.04ïŒïŒ®ïŒ3.73ïŒClïŒ9.43 å®æž¬å€ïŒïŒ£ïŒ70.13ïŒïŒšïŒ7.79ïŒïŒ®ïŒ3.57ïŒ
ClïŒ9.25 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒâ
ããããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5200ïŒã®è£œé ãã®å®æœäŸã¯è¡šèšååç©ã®äžéäœã®è£œæ³ãå å«
ããã  ïŒÎ²âãšãã«âïŒâã¡ããã·â17âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ïŒTR5174ïŒ ãšãã«ãªããŠã ã¯ã30mlã®ãšãŒãã«äžã«çŽ°ã
ãåæ£ãããªããŠã ã«ãã¢ã«ãŽã³äžã20mlã®ãš
ãŒãã«äžã®ãšãã«ã¯ãã©ã€ãïŒ3.1mlã42ããª
ã¢ã«ïŒã滎äžããããšã«ãããïŒâã§çŽ20åé
æ¹æããããšã«ãã補é ããããã®æ··åç©ãâ
78âã«å·åŽããåŸãåŸããããµã¹ãã³ãžãšã³
ããã¢ã«ãŽã³ã®å å§äžã«ãçŽâ78âã§æ¹æãã
ãŠãã200mlã®ãšãŒãã«äžã®CuIïŒ4.00ïœïŒ21ã
ãªã¢ã«ïŒã®ãµã¹ãã³ãžãšã³ã«ç§»ããããã®ãµã¹
ãã³ãžãšã³ãçŽâ40âãŸã§å æž©ãããã®æž©åºŠã«
çŽ10åéä¿æããã次ãã§ããã³ãŒã³ïŒ50mlïŒ
äžã®ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒ4.77ïœïŒ16.8
ããªã¢ã«ïŒã®æº¶æ¶²ãããã®ãµã¹ãã³ãžãšã³ã«
滎ã ãšéãã«æ·»å ããããã®éã枩床ãçŽâ40
âã«ä¿æãããŸãã10åéæ¹æãããåŸããã
æ··åç©ãïŒâã«å æž©ããã ãã®åå¿æ··åç©ã飜åNH4Cl溶液ïŒ300mlïŒ
ã§åŠçããçæç©ãå®æœäŸïŒã«èšèŒããããã«
ããŠã¯ãããã«ã ã§æœåºãããçæç©
TR5174ã5.5ïœãã·ããããšããŠåŸããããã
ã®çæç©ãå®æœäŸ1Aã«èšèŒããããã«ããŠ
HClå¡©ã«å€æããMeOHâEtOAcããçµæ¶åã
ããŠ4.22ïœïŒ71ïŒ ïŒã®çæç©ãm.p.257âïŒå
解ïŒãåŸããåãäžçµã®æº¶åªç³»ããåçµæ¶ã
ããçŽç²ãªTR5174ã»HClãmp263ã265âãåŸ
ãã å çŽ åæãèšç®å€ïŒC20H27NO2ã»HClïŒïŒïŒ£ïŒ
68.65ïŒïŒšïŒ8.07ïŒïŒ®ïŒ4.00 å®æž¬å€ïŒïŒ£ïŒ68.76ïŒïŒšïŒ8.02ïŒïŒ®ïŒ3.70  17âã·ã¢ãâïŒÎ²âãšãã«âïŒâã¡ããã·â
ïŒâãªã³ ïŒÎ²âãšãã«âïŒâã¡ããã·â17âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¡ã§è£œé ããã
ã®ïŒã®æ¥éãªæ¹æ溶液ã«å®æœäŸ1Bã«ãããã
ãã«ããŠã·ã¢ãã²ã³ãããã€ããæ·»å ãããç
æç©ã¯73ïŒ ã§åŸããããm.p.141ã145âã  ïŒÎ²âãšãã«âïŒâã¡ããã·ã¢ã«ãã€ãã³â
ïŒâãªã³å¡©é žå¡© 17âã·ã¢ãâïŒÎ²âãšãã«âïŒâã¡ãã«ã¢ã«
ãã€ãã³âïŒâãªã³ã®è©Šæããå®æœäŸ1Cã«èš
èŒãããšåæ§ã«ããŠ2N HClã§åŠçãããçæ
ç©ã¯72ïŒ ã®åçã§åé¢ããããmp280âã  17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒ
âã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5192ïŒ äžèšïŒ£ã§è£œé ãããïŒÎ²âãšãã«âïŒâã¡ã
ãã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ã®è©Šæãå®
æœäŸïŒã«ãããããã«ããŠåŠçãããå¡©é žå¡©ãš
ããŠã®åçã¯77ïŒ ã§ãã€ããmp252ã254âã å çŽ åæãèšç®å€ïŒC24H33NO2ã»HClïŒïŒïŒ£ïŒ
71.35ïŒïŒšïŒ8.48ïŒïŒ®ïŒ3.47 å®æž¬å€ïŒïŒ£ïŒ71.08ïŒïŒšïŒ8.32ïŒïŒ®ïŒ3.25  17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒ
âããããã·ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5200ïŒ äžèšïŒ€ã§è£œé ãã17âã·ã¯ãããã«ã¡ãã«â
ïŒÎ²âãšãã«âïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒ
âãªã³ã®è©Šæããå®æœäŸïŒã«èšèŒãããšåæ§ã«
ããŠåŠçãããçæç©ã¯HClå¡©ãšããŠåŸãã
ããåç98ïŒ ãmp190âïŒçºæ³¡ã䌎ã€ãŠå
解ïŒã å çŽ åæãèšç®å€ïŒC23H31NO2ã»HClã»
0.5C2H5OHïŒïŒïŒ£ïŒ69.86ïŒïŒšïŒ8.53ïŒïŒ®ïŒ
3.40 å®æž¬å€ïŒïŒ£ïŒ69.84ïŒïŒšïŒ8.53ïŒïŒ®ïŒ3.23 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·âïŒ
βâïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡©ïŒTR5204ïŒã®è£œé ãã®å®æœäŸã¯ãè¡šèšååç©ã®äžéäœã®è£œé ãå
å«ããŠããã  ïŒâã¡ããã·â17âã¡ãã«âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒTR5175ïŒ ïœâãããã«ãªããŠã ãããããã«ã¯ãã©ã€
ãïŒ42ããªã¢ã«ïŒãšéå±ãªããŠã ïŒ86ããªã¢
ã«ïŒãšãã補é ãã次ãã§ããšãŒãã«äžã®Cul
ïŒ21ããªã¢ã«ïŒã«â78âã§æ·»å ãïŒå®æœäŸ4Aå
ç §ïŒããªããŠã âãžâïœâãããã«é è©Šè¬ã補
é ããããã®ååç©ãïŒïŒïŒâãžããããâïŒ
âã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãª
ã³ïŒ16.8ããªã¢ã«ïŒãšåå¿ãããããã®çæç©
ïŒTR5175ïŒãå®æœäŸ1Aã«ãããããã«ããŠã
ã·ããããšããŠåé¢ããããã®ãã®ã¯æŸçœ®ããŠ
ãããšçµæ¶åããããã®ã·ããããHClå¡©ã«å€
æããMeOHâEtOAcããçµæ¶åãã4.28ïœ
ïŒ70ïŒ ïŒã®TR5175ã»HClãmp234ã235âãåŸ
ããåçµæ¶ã«ããçŽç²ãªTR5175ã»HClã
mp235ã237âãåŸãã å çŽ åæãèšç®å€ïŒC21H29NO2ã»HClïŒïŒïŒ£ïŒ
69.31ïŒïŒšïŒ8.31ïŒïŒ®ïŒ3.85 å®æž¬å€ïŒïŒ£ïŒ69.70ïŒïŒšïŒ8.42ïŒïŒ®ïŒ3.86  17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ ïŒâã¡ããã·â17âã¡ãã«âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¡ã§è£œé ã
ããã®ïŒã®æ¥éãªæ¹æ溶液ã«ãå®æœäŸ1Bã«ã
ããããã«ããŠã·ã¢ãã²ã³ãããã€ããæ·»å ã
ããçæç©ã¯97ïŒ ã®åçã§ã·ããããšããŠåŸã
ããæŽã«ç²Ÿè£œããããšãªã䜿çšããã  ïŒâã¡ããã·âïŒÎ²âïœâãããã«ã¢ã«ãã€
ãã³âïŒâãªã³å¡©é žå¡© 17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã®è©Šæããå®æœäŸ
1Cã«èŒããããã«ããŠåŠçãããçæç©ã¯ã
57ïŒ ã®åçã§åé¢ããããmpïŒ280âã  17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒ
βâïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5197ïŒ äžèšïŒ£ã§è£œé ããïŒâã¡ããã·âïŒÎ²âïœâ
ãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ã®è©Šæ
ãå®æœäŸïŒã«ãããããã«ããŠåŠçãããå¡©é ž
å¡©ãšããŠã®åçã¯46ïŒ ã§ãã€ããmp192ã193
âã å çŽ åæãèšç®å€ïŒC25H35NO2ã»HClïŒïŒïŒ£ïŒ
71.83ïŒïŒšïŒ8.68ïŒïŒ®ïŒ3.35 å®æž¬å€ïŒïŒ£ïŒ71.45ïŒïŒšïŒ8.39ïŒïŒ®ïŒ3.20  17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·â
ïŒÎ²âïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©
é žå¡©ïŒTR5204ïŒ äžèšïŒ€ã§è£œé ãã17âã·ã¯ãããã«ã¡ãã«â
ïŒâã¡ããã·âïŒÎ²âïœâãããã«ã¢ã«ãã€ã
ã³âïŒâãªã³ã®è©Šæããå®æœäŸïŒã«ããããã
ã«ããŠåŠçãããçæç©ã¯ãå¡©é žå¡©ãšããŠåç
99ïŒ ã§åŸããããmp210ã212âã å çŽ åæãèšç®å€ïŒC24H32NO2ã»HClïŒïŒïŒ£ïŒ
71.35ïŒïŒšïŒ8.48ïŒïŒ®ïŒ3.47 å®æž¬å€ïŒïŒ£ïŒ71.35ïŒïŒšïŒ8.38ïŒïŒ®ïŒ3.26 å®æœäŸ ïŒ åèååç©ã®è£œé TR5148  ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³â
ïŒâãªã³ ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒãµã¯ãã«ã
ãèšèŒãããããã«ããŠè£œé ãããããã©ã
ããã³ã¬ã¿ãŒãº20ïŒ2247ïŒ1964ïŒïŒã®è©Šæ2.0
ïœãã300mlã®95ïŒ ãšã¿ããŒã«ã«æº¶è§£ãã150
mgã®10ïŒ PdïŒïŒ£è§ŠåªãçšããŠã50psiã§ïŒæ
éãæ°ŽçŽ åããããã®æº¶æ¶²ãéããèžçºã
ããšãçµæ¶æ§æ®æž£ãçæããã ãã®çæç©ããšã¿ããŒã«ããåçµæ¶ãããš
760mgã®çæç©ãmp187ã188.5âïŒæç®ã
mp188ã189âïŒãåŸãããã å çŽ åæãèšç®å€ïŒC15H23NO2ïŒïŒïŒ£ïŒ75.76ïŒ
ïŒ8.12ïŒïŒ®ïŒ4.91 å®æž¬å€ïŒïŒ£ïŒ75.58ïŒïŒšïŒ7.95ïŒïŒ®ïŒ4.79  17âã·ã¢ãâïŒâã¡ããã·ã¢ã«ãã€ãã³â
ïŒâãªã³ 6.09ïœã®ä¹Ÿç¥K2CO3ãå«æããã¯ãããã«
ã 85mläžã®ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ã
ã€ãã³âïŒâãªã³ïŒäžèš6Aã«ãããããã«
ããŠè£œé ãããã®ïŒã®è©Šæ8.4ïœãã3.8ïœã®
ã·ã¢ãã²ã³ãããã€ããšåå¿ããããããŠã
å®æœäŸ1Bã«èšèŒããããã«ããŠçæç©ãå
é¢ãããçæç©ããšã¿ããŒã«ããçµæ¶åãã
ããåç6.96ïœïŒ80ïŒ ïŒãmp211ã214âã  ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡© 200mlã®2NHCläžã®17âã·ã¢ãâïŒâã¡ã
ãã·ã¢ã«ãã€ãã³âïŒâãªã³ïŒ6.9ïœãäžèš
ã§è£œé ãããã®ïŒã®ãµã¹ãã³ãžãšã³ããïŒ
æééæµããããåŸããã溶液ãå®æœäŸ1C
ã«ãããããã«ããŠåŠçãã5.2ïœã®çµæ¶ç
æç©ãmp190ã200âããåŸããæ¯æ¶²ããæŽ
ã«0.9ïœã®çæç©ãåŸããããå šåçã¯6.1ïœ
ïŒ85ïŒ ïŒã§ãã€ãã  17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·ã¢
ã«ãã€ãã³âïŒâãªã³ïŒTR5148ïŒ ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡©ïŒ3.5ïœïŒ0.011ã¢ã«ãäžèšïŒ£ã§è£œé ããã
ã®ïŒã®è©Šæããã·ã¯ãããã«ã¡ãã«ãããã€
ãã®2.56ïœïŒ0.017ã¢ã«ïŒã§åŠçãããã
ãŠãçæç©ïŒ2.4ïœïŒãå®æœäŸïŒã«ãããã
ãã«ããŠåé¢ãããçæç©ãå®æœäŸ1Aã«èš
èŒããããã«ããŠå¡©é žå¡©ã«å€æãããããŠã
ã¡ã¿ããŒã«âé ¢é žãšãã«ããåçµæ¶ããã
ãšã1.4ïœã®TR5148ãçæãããmp272ã
274âïŒå解ïŒã å çŽ åæãèšç®å€ïŒC22H29NO2ã»HClïŒïŒïŒ£ïŒ
70.29ïŒïŒšïŒ8.04ïŒïŒ®ïŒ3.73ïŒClïŒ9.43 å®æž¬å€ïŒïŒ£ïŒ70.16ïŒïŒšïŒ7.86ïŒïŒ®ïŒ3.66ïŒ
ClïŒ9.50 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·ã¢
ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒTR5153ïŒ TR5148ïŒ1.0ïœãäžèš1Dã§è£œé ãããã®ïŒ
ã®è©Šæããèåæ°ŽçŽ é žãšåå¿ããããããŠãç
æç©ãå®æœäŸïŒã«ãããããã«ããŠåé¢ããã
çæç©ã®åéã¯782mgã§ãã€ããHClå¡©ã«å€æ
ããã®ã¡ãçæç©ãã¡ã¿ããŒã«âé ¢é žãšãã«ã
ãçµæ¶åãããšã420mgã®TR5153ãmp262ã
264âïŒå解ïŒãçæããã å çŽ åæãèšç®å€ïŒC21H27NO2ã»HClïŒïŒïŒ£ïŒ
69.69ïŒïŒšïŒ7.80ïŒïŒ®ïŒ3.87ïŒClïŒ9.80 å®æž¬å€ïŒïŒ£ïŒ69.41ïŒïŒšïŒ7.90ïŒïŒ®ïŒ3.91ïŒ
ClïŒ9.91 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·ã¢
ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒTR5152ïŒ ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒ3.08ïœã10ããªã¢ã«ãäžèš1Cã§è£œé ããã
ã®ïŒã®è©Šæããå®æœäŸ1Dã«èšèŒãããšåæ§ã«
ããŠãçé žæ°ŽçŽ ãããªãŠã ã®ååšäžã§ã·ã¯ãã
ããã«ã¡ãã«ãããã€ããšåå¿ãããã20ïŒ
1VïŒïŒ¶ã¯ãããã«ã ïŒã¡ã¿ããŒã«ãçšããã·
ãªã«ã²ã«ïŒ§ã®ã¯ãããã°ã©ãã«ããã2.5ïœã®
ææã®çæç©ãã·ããããšããŠåé¢ããããã
ãã¯å¡©é žå¡©ã«å€æããã2.1ïœïŒ58ïŒ ïŒã®
TR5152ãmp265ã267âããçæããã å®æœäŸ ïŒ è¬çåŠçè©äŸ¡ æ¬çºæã®ååç©ã¯ã次ã®çç©æŽ»æ§ãèŠãåºãã¹
ãã¹ã¯ãªãŒãã³ã°ã«ä»ãããã ãã ããŠã¹ã«ãããé®çäœçšïŒé ¢é žã©ã€ãžã³
ã°ïŒwrithingïŒãã¹ãïŒïŒ ãã ã©ããã«ãããå¬ç æ§æ®æäœçšïŒæ¹è¯ã©
ããå°Ÿããªãã¯ïŒflickïŒãã¹ãïŒïŒ è©ŠéšïŒ¡ ããŠã¹ã®é ¢é žã©ã€ãžã³ã°ãã¹ã 被éšååç©ã®é®çäœçšã¯ãB.J.R.Whittle.Brit.
J.Pharmacol.22ïŒ246ïŒ1964ïŒã«èšèŒãããé ¢é ž
ã©ã€ãžã³ã°ãã¹ããéããããŠã¹ã«ãããŠæ±ºå®ã
ããã è¬ç©ã®å°ããšãïŒã€ã®ããŒãºïŒdoseïŒã¬ãã«
ã§ãåããŒãºåœãïŒå¹ã®ããŠã¹ãçšãED50ã決
å®ãããéæ§ã¢ã«ãããã€ãŒã«ã¹ãªããŒããŠã¹
ïŒalbino Charles River mouseïŒ18ã22ïœïŒãã
ãã®ç 究ã«çšããã æ¯èŒåç©ã«ã¯ãè ¹è å 泚å°ã«ãã0.5ïŒ ã®é ¢é ž
溶液0.4mlãäžãããïŒååŸã«ãã©ã€ãº
ïŒwrithesãè ¹éšã®äŒžé·ïŒabdominal strechingïŒïŒ
ã®20åéã«ãããå šæ°ãæ°ããã åŠçåç©ã«ã¯ãç®äžæ³šå°ã«ãã被éšååç©ãäž
ããã15ååŸã«ãè ¹è å 泚å°ã«ãã0.5ïŒ ã®é ¢é ž
溶液0.4mlãäžããã次ãã§ãæ¯èŒåç©ã«å¯ŸããŠ
èšèŒãããšåæ§ã«ããŠåæ±ã€ããããŒã¿ã¯æ¬¡åŒã
ãèšç®ããŠæ±ããã ïŒ é»æ¢ïŒæ¯èŒïŒã©ã€ãºæ°ïŒâåŠçïŒã©ã€ãºæ°ïŒÃïŒïŒïŒïŒæ¯èŒïŒã©ã€ãºæ°ïŒ ããŒã¿ã察æ°çŽã«ãããããããããŠãED50
å€ã¯ã90ïŒ ä¿¡é Œéçã§ãLitchfieldããã³
WilcoxonïŒJ.Pharmacol.Exp.Ther.96ïŒ99
ïŒ1949ïŒïŒã®æ¹æ³ã«ããæ±ããã è©ŠéšïŒ¢ å¬ç æ§æ®æ掻æ§ã®è©äŸ¡ 被éšååç©ã®å¬ç æ§æ®æäœçšã¯ãHarrisããã³
PiersonïŒJ.Pharmacol.Exp.Therap.143ïŒ141
ïŒ1964ïŒïŒã®ã©ããå°Ÿããªãã¯æ¹æ³ã®æ¹è¯æ³ã«ãã
決å®ãããã éæ§ã¢ã«ãããŠã€ã¹ã¿ãŒã©ããïŒalbino
Wistar RatsïŒ100ã120ïœïŒãããã®ç 究ã«çšã
ããã©ããã®å°Ÿãããã»ã«ïŒphotocellïŒãèŠã
ããã«äœçœ®ãããããç±ã¯ãåå°é¡å ã®ã©ã³ãã«
ããäŸçµŠãããã¿ã€ããŒãã©ã³ããšå é»ç®¡ã«çµå
ãããå ãç¹ç¯ãããšãã¿ã€ããŒã¯é²ã¿ãå é»ç®¡
ã被èŠãããªããŠããªããšãå ã¯ç¹ç¯ããªããã
ã«ããã å ç±ã©ã³ãã«å èµãããå æžæµæåšã¯ãããã
ãã®ã©ããã®æ¯èŒåå¿æéãïŒãïŒç§ãšãªããã
ã«ã©ããã®å°Ÿã«æäžãããå ã®åŒ·åºŠã調ç¯ããã
ãã«çšãããããæ¯èŒåå¿æéããã®ç¯å²å€ã«ã
ãåç©ã¯ãæé€ãããå æžæµæåšã®èª¿ç¯ã¯ãåå¿
æéã®éèŠãªå²åïŒå10å¹ã®ã©ããåœãïŒå¹ä»¥
äžïŒãïŒãïŒç§ããå€ããå Žåã®ã¿ãè¡ã€ãã
倫ã ã®æéæ¯ã«ïŒå¹ã®ã©ãããããªã矀ã䜿çšã
ãããããŠãïŒã€ã®æ¯èŒæéãè¬ç©ã®ç®äžæ³šå°ã«
å ç«ã¡60åæããã³30åæã«ãããŠæ±ºå®ãããã
10ç§éã§é®æããæ¹æ³ãæ¡çšãããããªãã¡ãã©
ããã10ç§éã®éã«ãå°Ÿãã±ã¡ã€ãšæããªãå Žå
ã«ã¯ãç±æºããé€å»ãããæåŸã®æ¯èŒå®éšãã30
åããŠã被éšè¬ãäžããããããã15åã«ãã¢ã«
ãã€ã³ã®ED50ããŒãºãè ¹è å æäžãããã¢ã«ã
ã€ã³ã泚å°ããŠåŸ20åæã«ãåç©ãåè©Šéšããã
æ¯èŒåç©ã«ã¯ã賊圢å€ããã³ã¢ã«ãã€ã³ã®ã¿ãäž
ãããããŒã¿ã¯æ¬¡ã®ããã«èšç®ããŠåŸãã ïŒ å¹æããïŒïœïŒïŒ²ïŒŽãïŒåŠçïŒâïŒïŒ²ïŒŽïŒæ¯èŒïŒïœÃïŒïŒïŒïŒïŒïŒâïŒïŒ²ïŒŽïŒæ¯èŒïŒ ïŒ æ®æäœçšïŒïœïŒ¥ïŒã¢ã«ãã€ã³ãæ¯èŒïŒâïŒè¬ç©åŠçïŒïœïŒïŒ¥ïŒã¢ã«ãã€ã³ãæ¯èŒïŒÃ100 ãMRTã¯å¹³ååå¿æéãæå³ããŠããã ããŒã¿ã察æ°æ¹çŒçŽã«ãããããããããŠã
AD50å€ãã95ïŒ ä¿¡é Œéçã§ãLitchfieldããã³
Wilcoxonã®æ¹æ³ã«ãã決å®ããã 衚ã¯ãæ¬çºæã®ååç©ããã³éžæãããåè
ååç©ãçšããäžèšè©Šéšã®çµæããŸãšãããã®ã§
ããã
çç°æ§é ãæããŠããã é žçŽ æ¶æ©ãååšããªããšãããã®ç°ç³»ã¯ã次ã®
æ§é åŒ ãæããã¢ã«ãã€ãã³ç³»ãšåŒã°ãããåŒäžãççŽ
ååã®çªå·ããã³ç°æå®ã¯è¡šç€ºãããšããã§ã
ãã ã¢ã«ãã€ã³ããã³ãã®é¡çžäœã¯ãäž»ãšããŠãç
ã¿ã®è§£é€ã®ããã«çšããããïŒé®çïŒããããã¯
å¬ç æ§ã§ããããããŠãã®æ®ãã©ã®ãã®ã¯åŸå±ç
èªçºèœãæããŠãããäžã€çæ³çé®çå€ä»¥äžã®ã
ã®ãšããŠããä»ã®å¯äœçšãçã¥ãïŒååã䟿ç§ã
çºæ±ãåŒåžäœäžãç³åçž®å°ïŒã é®çïŒåç矀ïŒããã³å¬ç æ§æ®æäœçšã®é©åãª
茪éãæã€ååç©ã¯ãè¬ç©äŸåæ§ãããã¯è¬ç©åŒ
害ã®æ¬ é¥ç¡ãããŠãæ¿ããçã¿ãæå¶ããé®çå€
ãšããŠã®å¯èœæ§ãæãããã®ã§ããã ããã«èšèŒããé®çå¬ç æ®æå€ã®åºçºç©è³ªãšã
ãŠçšããããïŒïŒïŒâãžããããâïŒâã¡ããã·
â17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã¯ããµã¯ã
ãã³ããšãã«ãã€ãŠå ±åãããŠãããããã©ãã
ãã³ïŒTetrahedronïŒ20ïŒ2247ïŒ1964ïŒã以äž
âãµã¯âãšãããã ç±³åœç¹èš±3654280ïŒãµã¯ããå¡©é矩補è¬(æ ª)ã
1972ïŒïŒïŒïŒçºè¡ã以äžâå¡©é矩âãšããïŒã«
ã¯ãâãµã¯âã«ãã€ãŠå ±åãããååç©ã«é¢ä¿ã
ãããçš®ã®17âã¢ãªã«ã17âãžã¡ãã«ã¢ãªã«åã¯
17âã·ã¯ããããã«ã¡ãã«çœ®æïŒâããããã·â
ã¢ã«ãã€ãã³âïŒâãªã³ååç©ã®å¬ç æ§æ®æ掻æ§
ãå ±åãããŠããã ããããã·ã«åºåã¯ãšãŒãã«åºã®åŠãïŒâäœã
é žçŽ ååã§çœ®æãããã¢ã«ãã€ãã³âïŒâãªã³å
åç©ã¯ãã¿ããã«ãã€ãŠå ±åãããŠãããããã©
ãããã³ã¬ã¿ãŒãºïŒTetr.Lett.ïŒ1805ïŒ1960ïŒãã
ã»ããã±ãã«ã«ãã¢ãŒãã·ãŠãŒãã€ã«ã«ãã¬ã¿ã³
ïŒChem.Pharm.Bull.ïŒ14ïŒ445ïŒ1966ïŒãã¯ãïŒäœ
ããããªãžãã«åºã«ãã眮æãããããªãã·ãã
ã©ãããã³ãã€ã³ååç©ãå ±åããŠããã æ¬çºæã®äž»é¡ã«ã¯æ¬¡ã®ãã®ãå«ãŸããã (a) äžèšæ§é åŒã åŒäžãR1ã¯æ°ŽçŽ åååã¯ã¡ãã«åºã§ããã äœããR1ãæ°ŽçŽ ååã§ãããšãR2ã¯ã·ã¯ã
ããã«ã¡ãã«ã§ããã R2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯ããã
ã«ã¡ãã«åºã§ããã R3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«åºã§
ãããäœããR3ããšãã«åã¯ïœâãããã«ã§
ãããšãR1ã¯æ°ŽçŽ ååã§ããã ãæããååç©ããã³è¬çåŠçã«æŽ»æ§ãªãã®é ž
ä»å å¡©ã (b) äžèš(a)ã«ç€ºããæ§é ã®ååç©ã®æ²»çåŠçã«æ
å¹éããã®çš®ã®æ²»çãå¿ èŠãšããã人ã«æäž
ãããã®äººã«ç¡çèŠçãçããããæ²»çæ¹æ³ã (c) R1ãã¡ãã«åºã§ãããR2ãã·ã¯ããããã«
ã¡ãã«åã¯ã·ã¯ãããã«ã¡ãã«ã§ããããããŠ
R3ãã¡ãã«ããšãã«åã¯ïœâãããã«ã§ãã
æ§é åŒãæããååç©ããäžèšå·¥çšã«ãã補
é ããæ¹æ³ã (i) ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ããããã²ã³
åçåæ°ŽçŽ åã¯è³éŠæçåæ°ŽçŽ æº¶åªäžã§ããª
ããŠã ãžãšãã«é ããªããŠã ãžã¡ãã«é ãã
ã³ãªããŠã ãžâïœâãããã«é ãããªã矀ã
ãéžã°ãããªããŠã ãžææ©é è©Šè¬ãšå ±åœ¹ïŒïŒ
ïŒâä»å åå¿ã«ããåå¿ãããã (ii) ãã®åå¿æ··åç©ãã¢ã³ã¢ããŠã ååç©ã®æ°Ž
溶液ãšéãã«åå¿ãããïŒâã¢ã«ãã«åçæ
ç©ã補é ãã (iii) ãã®ïŒâã¢ã«ãã«åçæç©ãã·ã¢ãã²ã³ã
ã©ã€ããšåå¿ããããŠãïŒâã¢ã«ãã«å17â
ã·ã¢ãçæç©ã補é ãã (iv) ãã®ïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ãé±
é žã§å æ°Žå解ããŠãïŒâã¢ã«ãã«å17âãã«
çæç©ã補é ããããã³ (v) ãã®ïŒâã¢ã«ãã«å17âãã«çæç©ããã·
ã¯ããããã«ã¡ãã«ãããã€ãããã³ã·ã¯ã
ããã«ã¡ãã«ãããã€ããããªã矀ããéžã°
ããã¢ã«ãã«åå€ãšé žææå€ã®ååšäžã«åå¿
ãããŠãææãšãã(a)ã®ïŒâã¢ã«ãã«åâ
眮æååç©ãåŸãã (d) äžèš(c)ã®ååç©ããéæµæž©åºŠã«ãããŠå æ°Žå
解å€ã«ããè±ã¡ãã«åããããšãããªãR1ã
æ°ŽçŽ ã§ããäžèš(c)ã«ãããŠåŸãããæ§é ãæã
ãååç©ã補é ããæ¹æ³ã (e) äžèšæ§é åŒã åŒäžãR4ã¯æ°ŽçŽ ãã¡ãã«ãã·ã¢ãåã¯ã·ã¯
ãããã«ã¡ãã«åºãR5ã¯ã¡ãã«ããšãã«åã¯
ïœâãããã«åºãäœããR4ãæ°ŽçŽ ãã¡ãã«å
ã¯ã·ã¢ãã®ãšãã®ã¿R5ã¯ã¡ãã«ã§ããã ãæããååç©ãå å«ãããäžèš(a)ã®æ§é ãæ
ããååç©ã®è£œé ã«ããããæçšãªäžéäœã äžèšåŒã®ååç©ã¯ãïŒâäœã«ã¢ã«ãã«çœ®æåº
ãæã€æ°èŠãªç¹åŸŽãæããã¢ã«ãã€ãã³âïŒâãª
ã³ååç©ã®å æ¬çååç©çŸ€ãè¡šãããŠããã åŒäžãR1ã¯æ°ŽçŽ åååã¯ã¡ãã«åºãäœãã
R1ãæ°ŽçŽ ååã§ãããšãR2ã¯ã·ã¯ãããã«ã¡ã
ã«ã§ããïŒR2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯
ãããã«ã¡ãã«åºã§ããïŒR3ã¯ã¡ãã«ããšãã«
ããã³ïœâãããã«åºãããªã矀ããéžã°ãã
åºãäœããR3ããšãã«åã¯ïœâãããã«åºã§ã
ããšãR1ã¯æ°ŽçŽ ååã§ããã åŒäžãããã³åœ¢ã®ç·ïŒãïŒã¯èšèŒãããŠãã
ããã«çŽé¢ã®äžæ¹ã«çªãåºãŠãã眮æåºã瀺ããŠ
ããããããŠãβâæ¹äœãšåŒã°ããã åŒã®ïŒâ眮æã¢ã«ãã€ãã³âïŒâãªã³ååç©
ã¯ãææ©åã¯ç¡æ©é žã«ãã€ãŠè¬çåŠçã«æŽ»æ§ãªé ž
ä»å å¡©ã圢æãããé žä»å å¡©ã®äŸãšããŠã¯ãé ç³
é žå¡©ãå¡©é žå¡©ãèåæ°ŽçŽ é žå¡©ããã¬ã€ã³é žå¡©çã§
ããã奜ãŸããå¡©ã¯å¡©é žå¡©ã§ããã æ¬çºæè ã¯ãçš®ã 眮æãããïŒâã¡ããã·ïŒã
ãããã·ïŒã¢ã«ãã€ãã³âïŒâãªã³ã®ïŒäœã«äœçŽ
ã¢ã«ãã«åºãå°å ¥ãããšãæå€ã«ããïŒäœæ°ŽçŽ ã®
åã¿ã€ãã®ååç©ã«ã¯èŠãããªãå¬ç æ§æ®æ掻æ§
ãäžããããšãèŠãåºããã æ¬çºæã®ååç©ã¯ããã®çš®ã®æ²»çãèŠæ±ããã
å人ã®çã¿ã®åŠçœ®ã®ããã«æçšã§ãããâå人â
ãšã¯ã人éåã¯äººéã®ã¢ãã«ãšãªãå®éšåç©ãæ
å³ããŠããã æå¹éã¯å人ãå人ã«ãã€ãŠç°ãªãããé床ã®
å®éšãããªããšãåœæ¥è ã«ãã容æã«æ±ºå®ãã
ããååç©ã¯ãé泚ãéçµå£ãããã«ã«ãçŽè ž
åã¯å£è ã®åŠãå ¬ç¥æ £çšã®æ²»çæäžæ¹æ³ã«ãã€ãŠ
æäžããããšãã§ãããååç©ã®æäžåœ¢æ ã¯ã
補è¬ç§åŠã§èªç¥ãããæ¹æ³ã«ãã€ãŠè£œé ããããš
ãã§ããã R2ãã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯ãããã«
ã¡ãã«ã§ãããR3ãã¡ãã«ããšãã«åã¯ïœâã
ããã«ã§ããåŒã®ååç©ã¯ãâãµã¯âã«ãã€ãŠ
èšèŒãããããã«ããŠè£œé ãããå ¬ç¥ã®ååç©ã
ïŒïŒïŒâãžããããâïŒâã¡ããã·â17âã¡ãã«
ã¢ã«ãã€ãã³âïŒâãªã³ããªãã¡æåã®åºçºç©è³ª
ã ãããªããŠã ãžã¡ãã«é ããªããŠã ãžãšãã«é å
ã¯ãªããŠã ãžâïœâãããã«é ã®åŠããªããŠã ãž
ææ©é ãšïŒïŒïŒâä»å ã«ããåå¿ããããããšã«
ããåæããããïŒïŒïŒâä»å ã«ããããªããŠã
ãžææ©é ã®äœ¿çšã¯ããã¹ããŒïŒPosnerïŒã«ãã
èšèŒãããŠããããªãŒã¬ããã¯ãªã¢ã¯ã·ãšã³ãº
ïŒOrg.ReactionsïŒ19ïŒïŒïŒ1972ïŒãã ããããªããããã¹ããŒã¯ã¢ã«ãã€ãã³ç³»ã«ã
ãããã®çš®ã®åå¿ã®äœ¿çšã«ã€ããŠã¯æ瀺ããŠããª
ãã ãªããŠã ãžææ©é è©Šè¬ã¯ãã¡ãã«ããšãã«åã¯
ïœâãããã«ãªããŠã ã®ïŒã¢ã«åœéãå«ã溶液
ãããšãŒãã«ãããã©ããããã©ã³çã ã®åŠã溶
åªäžã®æ²åé çŽïŒã¢ã«åœéãå«ãæ¹æããããµã³
ãã³ãžãšã³ã«ãçªçŽ åã¯ã¢ã«ãŽã³ã®ç¡æ¹¿æ°é°å²æ°
äžã§æ·»å ããããšã«ãã補é ãããããªããŠã ãž
ã¡ãã«é ã¯ïŒâã§è£œé ããããªããŠã ãžãšãã«é
ããã³ãªããŠã ãžâïœâãããã«é ã¯â78âã§è£œ
é ãããâ40âãŸã§æž©ãŸã€ãŠãè¯ãã ïŒïŒïŒâãžããããâïŒâã¡ããã·â17âã¡ã
ã«ã¢ã«ãã€ãã³âïŒâãªã³ãã®ã¡ãã¬ã³ã¯ãã©
ã€ãããšãã¬ã³ã¯ãã©ã€ãããžã¯ãããšã¿ã³çã
ã®åŠãããã²ã³åçåæ°ŽçŽ æº¶åªåã¯ãã³ãŒã³ãã
ã«ãšã³ããã·ã¬ã³çã ã®åŠãè³éŠæçåæ°ŽçŽ æº¶åª
äžã®æº¶æ¶²ã¯ã奜ãŸããã¯äžæŽ»æ§ãªç¡æ¹¿æ°é°å²æ°äž
ã«ãããŠããªããŠã ãžææ©é ã®æ¹æããããµã¹ã
ã³ãžãšã³ã«æ·»å ããããããŠåå¿ãããçšããã
ãè©Šè¬ããªããŠã ãžã¡ãã«é ã®å Žåã«ã¯ãåå¿æ··
åç©ããååç©ãæ·»å ããŠããéäžïŒâã«ä¿æ
ããã®ã奜ãŸããããããŠããã®æ··åç©ã¯çŽïŒæ
éè¿æ¹æããããçšããããè©Šè¬ããªããŠã ãžãš
ãã«é åã¯ãªããŠã ãžâïœâãããã«é ã®å Žåã«
ã¯ãåå¿æ··åç©ããååç©ã®æº¶æ¶²ãæ·»å ããŠã
ãéäžããã³çŽ10åéã®åå¿æéã®éäžãçŽâ78
âãâ40âã«ä¿æããã®ãæãŸãããååç©å¯Ÿ
ãªããŠã ãžææ©é è©Šè¬ã®ã¢ã«æ¯ã¯ãïŒïŒïŒãïŒïŒ
ïŒã®ç¯å²ãæãŸããããã®å·¥çšã«ããããã³ãŒã³
ã®äœ¿çšã¯å¥œãŸããã åå¿æ··åç©ã¯ã奜ãŸããã¯çŽïŒâãŸã§æž©ãã
ããããããå¡©åã¢ã³ã¢ã³ãæ°Žé žåã¢ã³ã¢ããŠã
çã ã®åŠãã¢ã³ã¢ããŠã ååç©ã®æ°Žæº¶æ¶²ãšã奜ãŸ
ããã¯ããã®åå¿æ··åç©äžã«å«ãŸããé ã®ã¢ã«é
å°ã®ç¶æ ã§ãéããã«åå¿ãããããã åŸãããæ··åç©ã¯ãïŒæéè¿æ¹æããæ§é åŒ
ãæããïŒâã¢ã«ãã«åçæç©ãçæããã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã åŸãããæ··åç©ã®æ°Žçžãåé¢ãããããŠ50ïŒ æ°Ž
é žåãããªãŠã åã¯æ°Žé žåã«ãªãŠã ã®åŠã匷塩åº
ãæ·»å ããŠçŽPH12ã«èª¿ç¯ããã次ãã§ããã®å¡©åº
æ§æ°Žæº¶æ¶²ããšãŒãã«ãã¯ãããã«ã çã®åŠãé©åœ
ãªææ©æº¶åªã§æœåºããããã®ææ©æœåºç©ã¯æ¬¡ã
ã§ãæŽæµãã也ç¥ããããŠèžçºããæ§é åŒãæ
ããçæç©ãåé¢ããã åé¢ãããçæç©ã¯ããšãŒãã«ãã¯ãããã«
ã çã®åŠãé©åœãªææ©æº¶åªã奜ãŸããã¯ç¡æ°Žçé ž
ã«ãªãŠã åã¯çé žãããªãŠã ã®åŠãé©åœãªé žææ
å€ãå«æãããããã®ææ©æº¶åªã«æº¶è§£ããããã·
ã¢ãã²ã³ãããã€ããã·ã¢ãã²ã³ã¯ãã©ã€ãåã¯
ã·ã¢ãã²ã³ã¢ã€ãªãã€ãã®åŠãã·ã¢ãã²ã³ãã©ã€
ãã®æº¶æ¶²ãã次ãã§ããã®æ··åç©ã«ãã€ãããšæ·»
å ããããã®ãµã¹ãã³ãžãšã³ã¯ã奜ãŸããã¯çŽ20
âã溶åªã®éæµæž©åºŠã§çŽïŒæéãŸã§æ¹æãããæ§
é åŒã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã ãæãã17âã·ã¢ãçæç©ãçæããããã®ãµã¹
ãã³ãžãšã³ã¯ã奜ãŸããã¯ãäžæº¶æ§ç©ã®åé¢ã容
æã«ãããããªæž©åºŠãŸã§å·åŽããã次ãã§ããã®
äžæº¶æ§ç©ã¯éãããã¯é å¿åé¢ã«ããé€å»ã
ãããããŠæº¶åªãèžçºãããŠ17âã·ã¢ãçæç©
ãåé¢ããã ãã®17âã·ã¢ãçæç©ã¯ãå¡©é žãç¡«é žãç¡é ž
çãããã¯å¡©é žã®åŠãã奜ãŸããã¯1Nã6Nã®é±
é žäžã«æžæ¿ããããããŠãçŽïŒæéãŸã§éæµæž©åºŠ
ã«å ç±ãããŠå æ°Žå解ãããæ§é åŒã åŒäžãR3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«
åºã§ããã ãæããïŒâã¢ã«ãã«å17âãã«çæç©ãçæã
ããååç©ã¯ã溶åªãèžçºãããããšã«ããå¡©
é žå¡©ãšããŠåå¿æ··åç©ããåé¢ãããã ãã®ïŒâã¢ã«ãã«å17âãã«çæç©åã¯å Žå
ã«ãã€ãŠãã®å¡©é žä»å å¡©ãã次ãã§ã«ãªãŠã åã¯
ãããªãŠã çé žå¡©åã¯éçé žå¡©ã®åŠãé žææå€ã®
ååšäžã§ã·ã¯ããããã«ã¡ãã«ãããã€ãåã¯ã·
ã¯ãããã«ã¡ãã«ãããã€ãã®åŠãã¢ã«ãã«åå€
ãšåå¿ããããïŒâã¢ã«ãã«å17âãã«çæç©
察ã¢ã«ãã«åå€å¯Ÿé žææå€ã®ã¢ã«æ¯ã¯ããã®é åº
ã§ã奜ãŸããã¯ïŒïŒïŒïŒïŒãïŒïŒïŒïŒïŒã®ç¯å²ã§
ãããåå¿ã¯ã奜ãŸããã¯ãçŽ50âã110âã®æž©
床ã§ãçªçŽ åã¯ã¢ã«ãŽã³ã®åŠãäžæŽ»æ§ãªç¡æ¹¿æ°é°
å²æ°äžã«ãããŠããžã¡ãã«ãã«ã ã¢ããããžã¡ã
ã«ã¹ã«ãããµã€ãããšã¿ããŒã«çã ã®åŠã極æ§æ
æ©æº¶åªäžã§è¡ãªããããR1ãã¡ãã«åºã§ããã
R2ããã³R3ãäžèšãšåãã§ããæ§é åŒãæã
ãåå¿çæç©ã¯ã次ãã§ã溶åªæœåºãããã¯ã¯ã
ããã°ã©ãã€ãŒã®åŠãåœè©²åéã®æšæºçæ¹æ³ã«ã
ãåé¢ãããã R1ãæ°ŽçŽ ã§ããæ§é åŒãæããååç©ã¯ã
R1ãã¡ãã«åºã§ããååç©ããããªãžã³å¡©é ž
å¡©ãèåæ°ŽçŽ é žçã®åŠãå æ°Žå解å€ãçšããŠïŒ¯â
è±ã¡ãã«åããããšã«ããã補é ãããéæµæž©åºŠ
ã§çŽ10ã20åéãèåæ°ŽçŽ é žã奜ãŸããã¯çŽ48ïŒ
ã§çšããã®ãæãŸããã 氎溶解æ§ãå¢å€§ããçæç©ãåŸãããšãæãŸã
ãå Žåã«ã¯ãã®ææ©ã®åã¯ç¡æ©ã®é žä»å å¡©ã補
é ããããšãã§ãããè¬çåŠçã«èš±å®¹ãããé žä»
å å¡©ã®äŸã¯ãé ç³é žå¡©ãå¡©é žå¡©ãèåæ°ŽçŽ é žå¡©ã
ãã¬ã€ã³é žå¡©çã ã§ãããå¡©é žå¡©ã¯å¥œãŸãããã®
ã§ãããå¡©é žå¡©ã¯ã奜ãŸããã¯ããšãŒãã«åã¯é ¢
é žãšãã«ã®åŠãææ©æº¶åªã«ãã®éé¢ã®å¡©åºã溶解
ã溶解ããããããŠãããã«ã¬ã¹ç¶ã®å¡©åæ°ŽçŽ ã
å ããããšã«ãã€ãŠåŸãããããã¯äœçŽã¢ã«ã³ãŒ
ã«ã«ãã®éé¢ã®å¡©åºã溶解ãããå¡©é žæ°Žæº¶æ¶²ãæ·»
å ãããããŠæº¶åªãèžçºãããããšã«ãã€ãŠåŸ
ããçŽç²ãªå¡©ã¯ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœ
ãããããŒã«çãå å«ããäœçŽã¢ã«ã³ãŒã«ã®åŠã
溶åªãããããã«é ¢é žã¡ãã«ãé ¢é žãšãã«ãé ¢é ž
ã€ãœãããã«çã®åŠãäœçŽãšã¹ãã«ãå ãã次ã
ã§ã沞ãšããããŠã¢ã«ã³ãŒã«ãé€å»ããåçµæ¶ã«
ããã䟿å©ã«ååŸãããã å®æœäŸ ïŒ 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5119ïŒ ãã®å®æœäŸã¯ãè¡šèšååç©ã®äžéäœã®è£œæ³ãå
å«ããã  ïŒÎ²ïŒ17âãžã¡ãã«âïŒâã¡ããã·ã¢ã«ãã€
ãã³âïŒâãªã³ïŒTR5068ïŒ ãšãŒãã«âãã³ãŒã³äžã«ããã補é ãªããŠã ãžã¡ãã«é ã®æº¶æ¶²ã¯ãã¡ãã«ãªã
ãŠã ïŒ0.159ã¢ã«ããšãŒãã«ã®1.84M溶液86
mlãAlfa Chem.Co.補ïŒãæ²åé ïŒ15.1ïœã
0.0794ã¢ã«ïŒã®ç¡æ°ŽãšãŒãã«ã®ãµã¹ãã³ãžãš
ã³ã«æ·»å ããŠãã¢ã«ãŽã³é°å²æ°äžãïŒâã§è£œ
é ããããã®æº¶æ¶²ã«ãïŒïŒïŒâãžããããâ
ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³âïŒ
âãªã³ïŒ18.0ïœã0.064ã¢ã«ïŒâãµã¯âã«ã
ãèšèŒãããæ¹æ³ã§è£œé ããïŒã®ä¹Ÿç¥ãã³ãŒ
ã³æº¶æ¶²ã滎äžããŠå ãããããŠãåŸãããæ··
åç©ãçŽïŒâã§ïŒæéæ¹æããã次ãã§ãã
ã®æ··åç©ã飜åNH4Cl溶液ïŒ1LïŒã«æ³šå ¥
ãã宀枩ã§çŽ30åéæ¹æãããææ©çžãæ··å
ç©ããåé¢ãããããŠæ°Žçžã50ïŒ NaOH溶液
ãæ·»å ããŠçŽPH12ã«èª¿ç¯ãããåŸãããæ°Žçž
ãã次ãã§ãã¯ãããã«ã ã§ïŒåæœåºããã
ããŠãäžç·ã«ããææ©æœåºç©ã飜åNH4Cl溶
液ã§æŽæµããMgSO4ã§ä¹Ÿç¥ãããããŠèžçº
ããããåŸãããæ®æž£ãé ¢é žãšãã«ã«æº¶è§£
ãããããŠæº¶åªãèžçºããçµæ¶æ®æž£ãåŸãã
ãã®çµæ¶æ®æž£ãã掻æ§çåŠçã®åŸé ¢é žãšãã«
ããåçµæ¶ããã10.0ïœã®TR5068ãmp126
ã127âãåŸããæ¯æ¶²ããæŽã«3.0ïœã®çæç©
ãåŸãããå šåçã¯68ïŒ ã§ãã€ãããšã¿ããŒ
ã«ããã®åçµæ¶ã«ããçŽç²ãªTR5068ã
mp131ã132âãåŸãããã å çŽ åæãèšç®å€ïŒC19H25NO2ïŒïŒïŒ£ïŒ76.22ïŒ
ïŒ8.42ïŒïŒ®ïŒ4.68 å®æž¬å€ïŒïŒ£ïŒ76.16ïŒïŒšïŒ8.35ïŒïŒ®ïŒ4.49 TR5068ã®å¡©é žå¡©ã¯ãéé¢ã®å¡©åºããšã¿ã
ãŒã«ã«æº¶è§£ãããéå°ã®æ¿HClãå ãããã
ãŠæ··åç©ã也ç¥ãããŸã§èžçºãããŠè£œé ã
ããåŸãããæ®æž£ãæŽã«ãå ããšã¿ããŒã«
ã§ã次ãã§ïŒïŒ1VïŒïŒ¶ãšã¿ããŒã«ïŒãã³ãŒ
ã³ã§ããããŠæåŸã«ãã³ãŒã³ã«ããã¢ãŒãªã
ãããã¯æ³ã«ãã也ç¥ãããã也ç¥ããçæ
ç©ããšã¿ããŒã«âé ¢é žãšãã«ããçµæ¶åãã
ããšãTR5068ã»HClãmp274ã276âãäžã
ãã å çŽ åæãèšç®å€ïŒC19H25NO2ã»HClïŒïŒïŒ£ïŒ
67.94ïŒïŒšïŒ7.80ïŒïŒ®ïŒ4.17ïŒClïŒ10.13 å®æž¬å€ïŒïŒ£ïŒ68.35ïŒïŒšïŒ7.38ïŒïŒ®ïŒ4.01ïŒ
ClïŒ10.13 ãšãŒãã«âã¡ãã¬ã³ã¯ãã©ã€ãäžã«ããã
補é å®æœäŸ1Aã«èšèŒããããã«ããŠãã¡ãã«
ãªããŠã ïŒ0.131ã¢ã«ïŒããã³æ²åé ïŒ12.4
ïœã0.066ã¢ã«ïŒãšãã補é ãããªããŠã ãž
ã¡ãã«é ã®æº¶æ¶²ããã¢ã«ãŽã³äžã«ïŒâã§è£œé
ããããã®æº¶æ¶²ã«ãã¡ãã¬ã³ã¯ãã©ã€ã150
mläžã®ïŒïŒïŒâãžããããâïŒâã¡ããã·â
17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒ15.0
ïœã0.053ã¢ã«ããµã¯ã«åŸã€ãŠè£œé ããïŒã®
溶液ã滎äžãããåå¿ããå®æœäŸïŒã®ããã«
ããŠãæŽã«ãåŠçãããã¯ãããã«ã æœåºç©
ã®èžçºã«ããåŸãããæ®æž£ãé ¢é žãšãã«ãã
çµæ¶åãããTR5068 9.70ïœãåŸãïŒåç61
ïŒ ïŒã  17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ 1.5ïœã®åŸ®ç²åãã也ç¥K2CO3ãå«ãã¯ãã
ãã«ã äžã®ïŒÎ²ïŒ17âãžã¡ãã«âïŒâã¡ããã·
âã¢ã«ãã€ãã³âïŒâãªã³ïŒéé¢å¡©åºïŒäžèšïŒ¡
ã§è£œé ãããã®ïŒã®ã¯ãããã«ã äžã®æ··åç©
ïŒ1.0ïœïŒ10mlïŒãæ¥éã«æ¹æããããã«ã¯ãã
ãã«ã äžã®ã·ã¢ãã²ã³ãããã€ã溶液ïŒ1.2åœ
éïŒ1.0ïœïŒ20mlïŒãããã€ãããšæ»Žäžããã
ãã®æ··åç©ã30åéæ¥éã«æ¹æãã次ãã§ãæŽ
ã«ïŒæééæµäžã«å ç±ããã溶液ãå·åŽãã
éãã也ç¥ãããŸã§èžçºãããããŠãã¢ã«ã³ãŒ
ã«ã§å ±æ²žä¹Ÿç¥ãããm.p.202ã205âã®çµæ¶ç
æç©ã81ïŒ ã®åçã§åŸãããããã®ãã®ã¯ãæŽ
ã«ç²Ÿè£œããããšãªãã«ã䜿çšãããã  ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³â
ïŒâãªã³å¡©é žå¡© 2NâHCläžã®17âã·ã¢ãâïŒâã¡ããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¢ã§
補é ãããã®ïŒã®ãµã¹ãã³ãžãšã³ïŒïŒïœïŒ30
mlïŒãïŒæééæµãããåŸããã溶液ã也ç¥ã
ããŸã§èžçºããããšã¿ããŒã«ã§æ°åºŠã«ãããå ±
沞也ç¥ããããããŠããšã¿ããŒã«äžã«æžæ¿ãã
çµæ¶æ§æ®æž£ãæéããããã®çæç©ã¯ãæŽã«ç²Ÿ
補ããããšãªãã«ã䜿çšããããçµæ¶æ§ç©ã
m.p.204ã208âãã®åçã¯90ïŒ ã§ãã€ãã  17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·â
ïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5119ïŒ DMFäžã®ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«
ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒäžèšïŒ£ã§è£œé ãã
ãã®ïŒã®ãµã¹ãã³ãžãšã³ïŒïŒïœïŒ10mlïŒã«
NaHCO3ïŒ2.2åœéïŒeq.ïŒïŒããã³ã·ã¯ããã
ãã«ã¡ãã«ãããã€ãïŒ1.5eq.ïŒãšãå ããã
ãã®æ··åç©ããã¢ã«ãŽã³é°å²æ°äžã100âã§16
æéå ç±ãã次ãã§å·åŽãããæ··åç©ãé
ãã液ãé«æžå§äžã§èžçºãããæ®æž£ãåŸãã
æ®æž£ãæ°Žã«æº¶è§£ããæ¿NH4OHã§PHçŽ11ã«èª¿ç¯
ãããã³ãŒã³ã§ïŒåæœåºãããææ©çžã也ç¥
ããéãããããŠèžçºã«ããæ®æž£ãšãããã
ã®æ®æž£ãã15ïŒïŒïŒïŒ¶ïŒïŒ¶ïŒã¯ãããã«ã ïŒã¡
ã¿ããŒã«ãå±éå€ãšããŠçšããã·ãªã«ã²ã«ïŒ§ã«
ããã¯ãããã°ã©ããããçŽç²Ÿãªã¯ãããã°ã©
ãã®ãã©ã¯ã·ãšã³ãäžç·ã«ãããçæç©ã¯éé¢
å¡©åºãm.p.114ã115âããšããŠ72ïŒ ã®åçã§
çµæ¶ãšããŠåŸãããã å çŽ åæïŒèšç®å€ïŒC22H29NO2ïŒïŒïŒ£ïŒ77.84ïŒ
ïŒ8.61ïŒïŒ®ïŒ4.13 å®æž¬å€ïŒïŒ£ïŒ77.75ïŒïŒšïŒ8.33ïŒïŒ®ïŒ4.00 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒÎ²
âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5132ïŒ ïŒâã¡ããã·âïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒ
âãªã³å¡©é žå¡©ïŒäžèš1Cã§è£œé ãããã®ïŒã®è©Šæ
ããã·ã¯ããããã«ã¡ãã«ãããã€ããã·ã¯ãã
ãã«ã¡ãã«ãããã€ãïŒ1.5eq.ïŒã«æããä»ã¯å®
æœäŸ1Dã«ããããšåæ§ã«ããŠãåŠçãããçæ
ç©ãå®æœäŸ1Dã«ããããšåæ§ã«ããŠåé¢ããã
ããŠãå¡©é žå¡©ã«å€æãããåç34ïŒ ãm.p.217ã
220âã å çŽ åæãèšç®å€ïŒC23H31NO2ã»HClïŒïŒïŒ£ïŒ
70.84ïŒïŒšïŒ8.27ïŒïŒ®ïŒ3.59ïŒClïŒ9.50 å®æž¬å€ïŒïŒ£ïŒ70.47ïŒïŒšïŒ8.19ïŒïŒ®ïŒ3.48ïŒ
ClïŒ9.23 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·âïŒ
βâã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5130ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒÎ²
âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒå®æœäŸïŒã§è£œ
é ãããã®ïŒããã³48ïŒ HBr氎溶液ïŒå€«ã ã1.0
ïœïŒïŒmlïŒã®è©Šæãã140âã«äºãå ç±ãã油济
äžã§20åééæµããããæ··åç©ãæ°·äžã§å·åŽãã
30mlã®æ°Žã§åžéããããã®æ°Žæº¶æ¶²ããæ¿NH4OH
ãå ããããšã«ãããPHçŽ11ã«èª¿ç¯ããããã®å¡©
åºæ§æ··åç©ãã¯ãããã«ã ã§ïŒåæœåºãããã
ãŠããã®ææ©æœåºç©ãå®æœäŸ1Dã«ããããšåæ§
ã«åŠçãããæ®æž£ãå®æœäŸ1Dã«ããããšåæ§ã«
ããŠã·ãªã«ã²ã«ïŒ§ã®ã¯ãããã°ã©ãã«ãããçæ
ç©ãå¡©é žå¡©ãšããŠåé¢ãããåç84ïŒ ãmp150â
ïŒçºæ³¡ã䌎ã€ãŠå解ïŒã å çŽ åæãèšç®å€ïŒC22H29NO2ã»HClïŒïŒïŒ£ïŒ
70.29ïŒïŒšïŒ8.04ïŒïŒ®ïŒ3.73ïŒClïŒ9.43 å®æž¬å€ïŒïŒ£ïŒ70.13ïŒïŒšïŒ7.79ïŒïŒ®ïŒ3.57ïŒ
ClïŒ9.25 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒâ
ããããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5200ïŒã®è£œé ãã®å®æœäŸã¯è¡šèšååç©ã®äžéäœã®è£œæ³ãå å«
ããã  ïŒÎ²âãšãã«âïŒâã¡ããã·â17âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ïŒTR5174ïŒ ãšãã«ãªããŠã ã¯ã30mlã®ãšãŒãã«äžã«çŽ°ã
ãåæ£ãããªããŠã ã«ãã¢ã«ãŽã³äžã20mlã®ãš
ãŒãã«äžã®ãšãã«ã¯ãã©ã€ãïŒ3.1mlã42ããª
ã¢ã«ïŒã滎äžããããšã«ãããïŒâã§çŽ20åé
æ¹æããããšã«ãã補é ããããã®æ··åç©ãâ
78âã«å·åŽããåŸãåŸããããµã¹ãã³ãžãšã³
ããã¢ã«ãŽã³ã®å å§äžã«ãçŽâ78âã§æ¹æãã
ãŠãã200mlã®ãšãŒãã«äžã®CuIïŒ4.00ïœïŒ21ã
ãªã¢ã«ïŒã®ãµã¹ãã³ãžãšã³ã«ç§»ããããã®ãµã¹
ãã³ãžãšã³ãçŽâ40âãŸã§å æž©ãããã®æž©åºŠã«
çŽ10åéä¿æããã次ãã§ããã³ãŒã³ïŒ50mlïŒ
äžã®ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒ4.77ïœïŒ16.8
ããªã¢ã«ïŒã®æº¶æ¶²ãããã®ãµã¹ãã³ãžãšã³ã«
滎ã ãšéãã«æ·»å ããããã®éã枩床ãçŽâ40
âã«ä¿æãããŸãã10åéæ¹æãããåŸããã
æ··åç©ãïŒâã«å æž©ããã ãã®åå¿æ··åç©ã飜åNH4Cl溶液ïŒ300mlïŒ
ã§åŠçããçæç©ãå®æœäŸïŒã«èšèŒããããã«
ããŠã¯ãããã«ã ã§æœåºãããçæç©
TR5174ã5.5ïœãã·ããããšããŠåŸããããã
ã®çæç©ãå®æœäŸ1Aã«èšèŒããããã«ããŠ
HClå¡©ã«å€æããMeOHâEtOAcããçµæ¶åã
ããŠ4.22ïœïŒ71ïŒ ïŒã®çæç©ãm.p.257âïŒå
解ïŒãåŸããåãäžçµã®æº¶åªç³»ããåçµæ¶ã
ããçŽç²ãªTR5174ã»HClãmp263ã265âãåŸ
ãã å çŽ åæãèšç®å€ïŒC20H27NO2ã»HClïŒïŒïŒ£ïŒ
68.65ïŒïŒšïŒ8.07ïŒïŒ®ïŒ4.00 å®æž¬å€ïŒïŒ£ïŒ68.76ïŒïŒšïŒ8.02ïŒïŒ®ïŒ3.70  17âã·ã¢ãâïŒÎ²âãšãã«âïŒâã¡ããã·â
ïŒâãªã³ ïŒÎ²âãšãã«âïŒâã¡ããã·â17âã¡ãã«ã¢
ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¡ã§è£œé ããã
ã®ïŒã®æ¥éãªæ¹æ溶液ã«å®æœäŸ1Bã«ãããã
ãã«ããŠã·ã¢ãã²ã³ãããã€ããæ·»å ãããç
æç©ã¯73ïŒ ã§åŸããããm.p.141ã145âã  ïŒÎ²âãšãã«âïŒâã¡ããã·ã¢ã«ãã€ãã³â
ïŒâãªã³å¡©é žå¡© 17âã·ã¢ãâïŒÎ²âãšãã«âïŒâã¡ãã«ã¢ã«
ãã€ãã³âïŒâãªã³ã®è©Šæããå®æœäŸ1Cã«èš
èŒãããšåæ§ã«ããŠ2N HClã§åŠçãããçæ
ç©ã¯72ïŒ ã®åçã§åé¢ããããmp280âã  17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒ
âã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒTR5192ïŒ äžèšïŒ£ã§è£œé ãããïŒÎ²âãšãã«âïŒâã¡ã
ãã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ã®è©Šæãå®
æœäŸïŒã«ãããããã«ããŠåŠçãããå¡©é žå¡©ãš
ããŠã®åçã¯77ïŒ ã§ãã€ããmp252ã254âã å çŽ åæãèšç®å€ïŒC24H33NO2ã»HClïŒïŒïŒ£ïŒ
71.35ïŒïŒšïŒ8.48ïŒïŒ®ïŒ3.47 å®æž¬å€ïŒïŒ£ïŒ71.08ïŒïŒšïŒ8.32ïŒïŒ®ïŒ3.25  17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒ
âããããã·ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5200ïŒ äžèšïŒ€ã§è£œé ãã17âã·ã¯ãããã«ã¡ãã«â
ïŒÎ²âãšãã«âïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒ
âãªã³ã®è©Šæããå®æœäŸïŒã«èšèŒãããšåæ§ã«
ããŠåŠçãããçæç©ã¯HClå¡©ãšããŠåŸãã
ããåç98ïŒ ãmp190âïŒçºæ³¡ã䌎ã€ãŠå
解ïŒã å çŽ åæãèšç®å€ïŒC23H31NO2ã»HClã»
0.5C2H5OHïŒïŒïŒ£ïŒ69.86ïŒïŒšïŒ8.53ïŒïŒ®ïŒ
3.40 å®æž¬å€ïŒïŒ£ïŒ69.84ïŒïŒšïŒ8.53ïŒïŒ®ïŒ3.23 å®æœäŸ ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·âïŒ
βâïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡©ïŒTR5204ïŒã®è£œé ãã®å®æœäŸã¯ãè¡šèšååç©ã®äžéäœã®è£œé ãå
å«ããŠããã  ïŒâã¡ããã·â17âã¡ãã«âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒTR5175ïŒ ïœâãããã«ãªããŠã ãããããã«ã¯ãã©ã€
ãïŒ42ããªã¢ã«ïŒãšéå±ãªããŠã ïŒ86ããªã¢
ã«ïŒãšãã補é ãã次ãã§ããšãŒãã«äžã®Cul
ïŒ21ããªã¢ã«ïŒã«â78âã§æ·»å ãïŒå®æœäŸ4Aå
ç §ïŒããªããŠã âãžâïœâãããã«é è©Šè¬ã補
é ããããã®ååç©ãïŒïŒïŒâãžããããâïŒ
âã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãª
ã³ïŒ16.8ããªã¢ã«ïŒãšåå¿ãããããã®çæç©
ïŒTR5175ïŒãå®æœäŸ1Aã«ãããããã«ããŠã
ã·ããããšããŠåé¢ããããã®ãã®ã¯æŸçœ®ããŠ
ãããšçµæ¶åããããã®ã·ããããHClå¡©ã«å€
æããMeOHâEtOAcããçµæ¶åãã4.28ïœ
ïŒ70ïŒ ïŒã®TR5175ã»HClãmp234ã235âãåŸ
ããåçµæ¶ã«ããçŽç²ãªTR5175ã»HClã
mp235ã237âãåŸãã å çŽ åæãèšç®å€ïŒC21H29NO2ã»HClïŒïŒïŒ£ïŒ
69.31ïŒïŒšïŒ8.31ïŒïŒ®ïŒ3.85 å®æž¬å€ïŒïŒ£ïŒ69.70ïŒïŒšïŒ8.42ïŒïŒ®ïŒ3.86  17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ ïŒâã¡ããã·â17âã¡ãã«âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒäžèšïŒ¡ã§è£œé ã
ããã®ïŒã®æ¥éãªæ¹æ溶液ã«ãå®æœäŸ1Bã«ã
ããããã«ããŠã·ã¢ãã²ã³ãããã€ããæ·»å ã
ããçæç©ã¯97ïŒ ã®åçã§ã·ããããšããŠåŸã
ããæŽã«ç²Ÿè£œããããšãªã䜿çšããã  ïŒâã¡ããã·âïŒÎ²âïœâãããã«ã¢ã«ãã€
ãã³âïŒâãªã³å¡©é žå¡© 17âã·ã¢ãâïŒâã¡ããã·âïŒÎ²âïœâãã
ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã®è©Šæããå®æœäŸ
1Cã«èŒããããã«ããŠåŠçãããçæç©ã¯ã
57ïŒ ã®åçã§åé¢ããããmpïŒ280âã  17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·âïŒ
βâïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³
ïŒTR5197ïŒ äžèšïŒ£ã§è£œé ããïŒâã¡ããã·âïŒÎ²âïœâ
ãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ã®è©Šæ
ãå®æœäŸïŒã«ãããããã«ããŠåŠçãããå¡©é ž
å¡©ãšããŠã®åçã¯46ïŒ ã§ãã€ããmp192ã193
âã å çŽ åæãèšç®å€ïŒC25H35NO2ã»HClïŒïŒïŒ£ïŒ
71.83ïŒïŒšïŒ8.68ïŒïŒ®ïŒ3.35 å®æž¬å€ïŒïŒ£ïŒ71.45ïŒïŒšïŒ8.39ïŒïŒ®ïŒ3.20  17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·â
ïŒÎ²âïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³å¡©
é žå¡©ïŒTR5204ïŒ äžèšïŒ€ã§è£œé ãã17âã·ã¯ãããã«ã¡ãã«â
ïŒâã¡ããã·âïŒÎ²âïœâãããã«ã¢ã«ãã€ã
ã³âïŒâãªã³ã®è©Šæããå®æœäŸïŒã«ããããã
ã«ããŠåŠçãããçæç©ã¯ãå¡©é žå¡©ãšããŠåç
99ïŒ ã§åŸããããmp210ã212âã å çŽ åæãèšç®å€ïŒC24H32NO2ã»HClïŒïŒïŒ£ïŒ
71.35ïŒïŒšïŒ8.48ïŒïŒ®ïŒ3.47 å®æž¬å€ïŒïŒ£ïŒ71.35ïŒïŒšïŒ8.38ïŒïŒ®ïŒ3.26 å®æœäŸ ïŒ åèååç©ã®è£œé TR5148  ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ãã€ãã³â
ïŒâãªã³ ïŒïŒïŒâãžããããâïŒâã¡ããã·â17â
ã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ïŒãµã¯ãã«ã
ãèšèŒãããããã«ããŠè£œé ãããããã©ã
ããã³ã¬ã¿ãŒãº20ïŒ2247ïŒ1964ïŒïŒã®è©Šæ2.0
ïœãã300mlã®95ïŒ ãšã¿ããŒã«ã«æº¶è§£ãã150
mgã®10ïŒ PdïŒïŒ£è§ŠåªãçšããŠã50psiã§ïŒæ
éãæ°ŽçŽ åããããã®æº¶æ¶²ãéããèžçºã
ããšãçµæ¶æ§æ®æž£ãçæããã ãã®çæç©ããšã¿ããŒã«ããåçµæ¶ãããš
760mgã®çæç©ãmp187ã188.5âïŒæç®ã
mp188ã189âïŒãåŸãããã å çŽ åæãèšç®å€ïŒC15H23NO2ïŒïŒïŒ£ïŒ75.76ïŒ
ïŒ8.12ïŒïŒ®ïŒ4.91 å®æž¬å€ïŒïŒ£ïŒ75.58ïŒïŒšïŒ7.95ïŒïŒ®ïŒ4.79  17âã·ã¢ãâïŒâã¡ããã·ã¢ã«ãã€ãã³â
ïŒâãªã³ 6.09ïœã®ä¹Ÿç¥K2CO3ãå«æããã¯ãããã«
ã 85mläžã®ïŒâã¡ããã·â17âã¡ãã«ã¢ã«ã
ã€ãã³âïŒâãªã³ïŒäžèš6Aã«ãããããã«
ããŠè£œé ãããã®ïŒã®è©Šæ8.4ïœãã3.8ïœã®
ã·ã¢ãã²ã³ãããã€ããšåå¿ããããããŠã
å®æœäŸ1Bã«èšèŒããããã«ããŠçæç©ãå
é¢ãããçæç©ããšã¿ããŒã«ããçµæ¶åãã
ããåç6.96ïœïŒ80ïŒ ïŒãmp211ã214âã  ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡© 200mlã®2NHCläžã®17âã·ã¢ãâïŒâã¡ã
ãã·ã¢ã«ãã€ãã³âïŒâãªã³ïŒ6.9ïœãäžèš
ã§è£œé ãããã®ïŒã®ãµã¹ãã³ãžãšã³ããïŒ
æééæµããããåŸããã溶液ãå®æœäŸ1C
ã«ãããããã«ããŠåŠçãã5.2ïœã®çµæ¶ç
æç©ãmp190ã200âããåŸããæ¯æ¶²ããæŽ
ã«0.9ïœã®çæç©ãåŸããããå šåçã¯6.1ïœ
ïŒ85ïŒ ïŒã§ãã€ãã  17âã·ã¯ãããã«ã¡ãã«âïŒâã¡ããã·ã¢
ã«ãã€ãã³âïŒâãªã³ïŒTR5148ïŒ ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é ž
å¡©ïŒ3.5ïœïŒ0.011ã¢ã«ãäžèšïŒ£ã§è£œé ããã
ã®ïŒã®è©Šæããã·ã¯ãããã«ã¡ãã«ãããã€
ãã®2.56ïœïŒ0.017ã¢ã«ïŒã§åŠçãããã
ãŠãçæç©ïŒ2.4ïœïŒãå®æœäŸïŒã«ãããã
ãã«ããŠåé¢ãããçæç©ãå®æœäŸ1Aã«èš
èŒããããã«ããŠå¡©é žå¡©ã«å€æãããããŠã
ã¡ã¿ããŒã«âé ¢é žãšãã«ããåçµæ¶ããã
ãšã1.4ïœã®TR5148ãçæãããmp272ã
274âïŒå解ïŒã å çŽ åæãèšç®å€ïŒC22H29NO2ã»HClïŒïŒïŒ£ïŒ
70.29ïŒïŒšïŒ8.04ïŒïŒ®ïŒ3.73ïŒClïŒ9.43 å®æž¬å€ïŒïŒ£ïŒ70.16ïŒïŒšïŒ7.86ïŒïŒ®ïŒ3.66ïŒ
ClïŒ9.50 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·ã¢
ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒTR5153ïŒ TR5148ïŒ1.0ïœãäžèš1Dã§è£œé ãããã®ïŒ
ã®è©Šæããèåæ°ŽçŽ é žãšåå¿ããããããŠãç
æç©ãå®æœäŸïŒã«ãããããã«ããŠåé¢ããã
çæç©ã®åéã¯782mgã§ãã€ããHClå¡©ã«å€æ
ããã®ã¡ãçæç©ãã¡ã¿ããŒã«âé ¢é žãšãã«ã
ãçµæ¶åãããšã420mgã®TR5153ãmp262ã
264âïŒå解ïŒãçæããã å çŽ åæãèšç®å€ïŒC21H27NO2ã»HClïŒïŒïŒ£ïŒ
69.69ïŒïŒšïŒ7.80ïŒïŒ®ïŒ3.87ïŒClïŒ9.80 å®æž¬å€ïŒïŒ£ïŒ69.41ïŒïŒšïŒ7.90ïŒïŒ®ïŒ3.91ïŒ
ClïŒ9.91 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·ã¢
ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©ïŒTR5152ïŒ ïŒâã¡ããã·ã¢ã«ãã€ãã³âïŒâãªã³å¡©é žå¡©
ïŒ3.08ïœã10ããªã¢ã«ãäžèš1Cã§è£œé ããã
ã®ïŒã®è©Šæããå®æœäŸ1Dã«èšèŒãããšåæ§ã«
ããŠãçé žæ°ŽçŽ ãããªãŠã ã®ååšäžã§ã·ã¯ãã
ããã«ã¡ãã«ãããã€ããšåå¿ãããã20ïŒ
1VïŒïŒ¶ã¯ãããã«ã ïŒã¡ã¿ããŒã«ãçšããã·
ãªã«ã²ã«ïŒ§ã®ã¯ãããã°ã©ãã«ããã2.5ïœã®
ææã®çæç©ãã·ããããšããŠåé¢ããããã
ãã¯å¡©é žå¡©ã«å€æããã2.1ïœïŒ58ïŒ ïŒã®
TR5152ãmp265ã267âããçæããã å®æœäŸ ïŒ è¬çåŠçè©äŸ¡ æ¬çºæã®ååç©ã¯ã次ã®çç©æŽ»æ§ãèŠãåºãã¹
ãã¹ã¯ãªãŒãã³ã°ã«ä»ãããã ãã ããŠã¹ã«ãããé®çäœçšïŒé ¢é žã©ã€ãžã³
ã°ïŒwrithingïŒãã¹ãïŒïŒ ãã ã©ããã«ãããå¬ç æ§æ®æäœçšïŒæ¹è¯ã©
ããå°Ÿããªãã¯ïŒflickïŒãã¹ãïŒïŒ è©ŠéšïŒ¡ ããŠã¹ã®é ¢é žã©ã€ãžã³ã°ãã¹ã 被éšååç©ã®é®çäœçšã¯ãB.J.R.Whittle.Brit.
J.Pharmacol.22ïŒ246ïŒ1964ïŒã«èšèŒãããé ¢é ž
ã©ã€ãžã³ã°ãã¹ããéããããŠã¹ã«ãããŠæ±ºå®ã
ããã è¬ç©ã®å°ããšãïŒã€ã®ããŒãºïŒdoseïŒã¬ãã«
ã§ãåããŒãºåœãïŒå¹ã®ããŠã¹ãçšãED50ã決
å®ãããéæ§ã¢ã«ãããã€ãŒã«ã¹ãªããŒããŠã¹
ïŒalbino Charles River mouseïŒ18ã22ïœïŒãã
ãã®ç 究ã«çšããã æ¯èŒåç©ã«ã¯ãè ¹è å 泚å°ã«ãã0.5ïŒ ã®é ¢é ž
溶液0.4mlãäžãããïŒååŸã«ãã©ã€ãº
ïŒwrithesãè ¹éšã®äŒžé·ïŒabdominal strechingïŒïŒ
ã®20åéã«ãããå šæ°ãæ°ããã åŠçåç©ã«ã¯ãç®äžæ³šå°ã«ãã被éšååç©ãäž
ããã15ååŸã«ãè ¹è å 泚å°ã«ãã0.5ïŒ ã®é ¢é ž
溶液0.4mlãäžããã次ãã§ãæ¯èŒåç©ã«å¯ŸããŠ
èšèŒãããšåæ§ã«ããŠåæ±ã€ããããŒã¿ã¯æ¬¡åŒã
ãèšç®ããŠæ±ããã ïŒ é»æ¢ïŒæ¯èŒïŒã©ã€ãºæ°ïŒâåŠçïŒã©ã€ãºæ°ïŒÃïŒïŒïŒïŒæ¯èŒïŒã©ã€ãºæ°ïŒ ããŒã¿ã察æ°çŽã«ãããããããããŠãED50
å€ã¯ã90ïŒ ä¿¡é Œéçã§ãLitchfieldããã³
WilcoxonïŒJ.Pharmacol.Exp.Ther.96ïŒ99
ïŒ1949ïŒïŒã®æ¹æ³ã«ããæ±ããã è©ŠéšïŒ¢ å¬ç æ§æ®æ掻æ§ã®è©äŸ¡ 被éšååç©ã®å¬ç æ§æ®æäœçšã¯ãHarrisããã³
PiersonïŒJ.Pharmacol.Exp.Therap.143ïŒ141
ïŒ1964ïŒïŒã®ã©ããå°Ÿããªãã¯æ¹æ³ã®æ¹è¯æ³ã«ãã
決å®ãããã éæ§ã¢ã«ãããŠã€ã¹ã¿ãŒã©ããïŒalbino
Wistar RatsïŒ100ã120ïœïŒãããã®ç 究ã«çšã
ããã©ããã®å°Ÿãããã»ã«ïŒphotocellïŒãèŠã
ããã«äœçœ®ãããããç±ã¯ãåå°é¡å ã®ã©ã³ãã«
ããäŸçµŠãããã¿ã€ããŒãã©ã³ããšå é»ç®¡ã«çµå
ãããå ãç¹ç¯ãããšãã¿ã€ããŒã¯é²ã¿ãå é»ç®¡
ã被èŠãããªããŠããªããšãå ã¯ç¹ç¯ããªããã
ã«ããã å ç±ã©ã³ãã«å èµãããå æžæµæåšã¯ãããã
ãã®ã©ããã®æ¯èŒåå¿æéãïŒãïŒç§ãšãªããã
ã«ã©ããã®å°Ÿã«æäžãããå ã®åŒ·åºŠã調ç¯ããã
ãã«çšãããããæ¯èŒåå¿æéããã®ç¯å²å€ã«ã
ãåç©ã¯ãæé€ãããå æžæµæåšã®èª¿ç¯ã¯ãåå¿
æéã®éèŠãªå²åïŒå10å¹ã®ã©ããåœãïŒå¹ä»¥
äžïŒãïŒãïŒç§ããå€ããå Žåã®ã¿ãè¡ã€ãã
倫ã ã®æéæ¯ã«ïŒå¹ã®ã©ãããããªã矀ã䜿çšã
ãããããŠãïŒã€ã®æ¯èŒæéãè¬ç©ã®ç®äžæ³šå°ã«
å ç«ã¡60åæããã³30åæã«ãããŠæ±ºå®ãããã
10ç§éã§é®æããæ¹æ³ãæ¡çšãããããªãã¡ãã©
ããã10ç§éã®éã«ãå°Ÿãã±ã¡ã€ãšæããªãå Žå
ã«ã¯ãç±æºããé€å»ãããæåŸã®æ¯èŒå®éšãã30
åããŠã被éšè¬ãäžããããããã15åã«ãã¢ã«
ãã€ã³ã®ED50ããŒãºãè ¹è å æäžãããã¢ã«ã
ã€ã³ã泚å°ããŠåŸ20åæã«ãåç©ãåè©Šéšããã
æ¯èŒåç©ã«ã¯ã賊圢å€ããã³ã¢ã«ãã€ã³ã®ã¿ãäž
ãããããŒã¿ã¯æ¬¡ã®ããã«èšç®ããŠåŸãã ïŒ å¹æããïŒïœïŒïŒ²ïŒŽãïŒåŠçïŒâïŒïŒ²ïŒŽïŒæ¯èŒïŒïœÃïŒïŒïŒïŒïŒïŒâïŒïŒ²ïŒŽïŒæ¯èŒïŒ ïŒ æ®æäœçšïŒïœïŒ¥ïŒã¢ã«ãã€ã³ãæ¯èŒïŒâïŒè¬ç©åŠçïŒïœïŒïŒ¥ïŒã¢ã«ãã€ã³ãæ¯èŒïŒÃ100 ãMRTã¯å¹³ååå¿æéãæå³ããŠããã ããŒã¿ã察æ°æ¹çŒçŽã«ãããããããããŠã
AD50å€ãã95ïŒ ä¿¡é Œéçã§ãLitchfieldããã³
Wilcoxonã®æ¹æ³ã«ãã決å®ããã 衚ã¯ãæ¬çºæã®ååç©ããã³éžæãããåè
ååç©ãçšããäžèšè©Šéšã®çµæããŸãšãããã®ã§
ããã
ãè¡šã
衚äžãâcpmâã¯ã·ã¯ããããã«ã¡ãã«åºã
è¡šãããŠãããâcbmâã¯ã·ã¯ãããã«ã¡ãã«åº
ãè¡šãããŠããã äžèšçç©åŠçããŒã¿ã¯ãåèååç©ãããªã
ã¡ãTRçªå·5152ã5148ããã³5153ãšæ¯èŒããŠã
æ¬çºæã§è«æ±ããŠããååç©ãäºæã«åããé®ç
ããã³å¬ç æ®æ掻æ§ãæã€ãŠããããšãæçã«ç€º
ããŠããã
è¡šãããŠãããâcbmâã¯ã·ã¯ãããã«ã¡ãã«åº
ãè¡šãããŠããã äžèšçç©åŠçããŒã¿ã¯ãåèååç©ãããªã
ã¡ãTRçªå·5152ã5148ããã³5153ãšæ¯èŒããŠã
æ¬çºæã§è«æ±ããŠããååç©ãäºæã«åããé®ç
ããã³å¬ç æ®æ掻æ§ãæã€ãŠããããšãæçã«ç€º
ããŠããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžèšæ§é åŒã åŒäžãR1ã¯æ°ŽçŽ åååã¯ã¡ãã«åºã§ããã äœããR1ãæ°ŽçŽ ååã§ãããšãR2ã¯ã·ã¯ãã
ãã«ã¡ãã«ã§ãã R2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯ãããã«
ã¡ãã«åºã§ããã R3ã¯ã¡ãã«ããšãã«åã¯ïœâãããã«åºã§ã
ããäœããR3ããšãã«åã¯ïœâãããã«ã§ãã
ãšãR1ã¯æ°ŽçŽ ååã§ããã ãæããååç©ããã³ãã®è¬çåŠçã«æŽ»æ§ãªé žä»
å å¡©ã ïŒ 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·â
ïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 17âã·ã¯ããããã«ã¡ãã«âïŒâã¡ããã·â
ïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·â
ïŒÎ²âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒÎ²âãšãã«âïŒ
âããããã·ã¢ã«ãã€ãã³âïŒâãªã³ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ 17âã·ã¯ãããã«ã¡ãã«âïŒâããããã·â
ïŒÎ²âïœâãããã«ã¢ã«ãã€ãã³âïŒâãªã³ã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã®ååç©ã ïŒ äžèšå·¥çšã (a) ååç©ïŒïŒïŒâãžããããâïŒâã¡ããã·â
17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ããããã²
ã³åçåæ°ŽçŽ åã¯è³éŠæçåæ°ŽçŽ æº¶åªäžã§ããª
ããŠã ãžã¡ãã«é ãšå ±åœ¹ïŒïŒïŒä»å åå¿ã«ãã
åå¿ãããã (b) ãã®åå¿æ··åç©ãã¢ã³ã¢ããŠã ååç©ã®æ°Žæº¶
液ãšéããã«åå¿ãããåé¢ãããšäžèšæ§é
åŒã åŒäžãR5ã¯ã¡ãã«åºã§ããã ãæããïŒâã¢ã«ãã«åçæç©ã補é ãã (c) ãã®ïŒâã¢ã«ãã«åçæç©ãææ©æº¶åªäžã§ã·
ã¢ãã²ã³ãã©ã€ããšåå¿ããããŠãåé¢ãããš
äžèšæ§é åŒã åŒäžãR5ã®å®çŸ©ã¯äžèšã«åãã§ããã ãæããïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ã補
é ãã (d) ãã®ïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ãé±é ž
ã§å æ°Žå解ããŠãåé¢ãããšäžèšæ§é åŒã åŒäžãR5ã®å®çŸ©ã¯äžèšã«åãã§ããã ãæããïŒâã¢ã«ãã«å17âãã«çæç©ã補é
ãã (e) ãã®ïŒâã¢ã«ãã«å17âãã«çæç©ããã·ã¯
ããããã«ã¡ãã«ãããã€ãããã³ã·ã¯ããã
ã«ã¡ãã«ãããã€ããããªã矀ããéžã°ããã¢
ã«ãã«åå€ãšæ¥µæ§ææ©æº¶åªäžãé žææå€ã®ååš
äžã§åå¿ããããŠãææã®çæç©ã補é ããã
ããŠã (f) 該çæç©ãåé¢ããã ãããªãããšãç¹åŸŽãšããäžèšæ§é åŒã åŒäžãR2ã¯ã·ã¯ããããã«ã¡ãã«åã¯ã·ã¯
ãããã«ã¡ãã«åºã§ããã R3ã¯ã¡ãã«åºã§ããã ãæããååç©ã®è£œé æ¹æ³ã ïŒ äžèšå·¥çšã (a) ïŒïŒïŒâãžããããâïŒâã¡ããã·â17âã¡
ãã«ã¢ã«ãã€ãã³ïŒâãªã³ååç©ãããªããŠã
ãžã¡ãã«é è©Šè¬ãšããã®é åºã§ã¢ã«æ¯ïŒïŒïŒã
ïŒïŒïŒã§ãçŽâ40âãïŒâã§ãäžæŽ»æ§ç¡æ¹¿æ°é°
å²æ°äžã«åå¿ãããã (b) ãã®åå¿æ··åç©ããåå¿æ··åç©äžã«ååšãã
é ã®ã¢ã«éå°éã§ãã¢ã³ã¢ããŠã ååç©ã®æ°Žæº¶
液ãšéããã«åå¿ããã (c) çæããïŒâã¢ã«ãã«åçæç©ããçŽ20âã
溶åªã®éæµæž©åºŠã§æ倧éïŒæéã·ã¢ãã²ã³ãã©
ã€ããšåå¿ããã (d) çæããïŒâã¢ã«ãã«å17âã·ã¢ãçæç©
ããéæµæž©åºŠã§ãå¡©é žãç¡«é žããã³ç¡é žãããª
ã矀ããéžã°ããé±é žã®åžé液ã§å æ°Žå解ãã
ãããŠã (e) çæããïŒâã¢ã«ãã«å17âãã«çæç©ãšã¢
ã«ãã«åå€ãšããé žææå€ã®ååšäžã«ããã®é
åºã§ã¢ã«æ¯ïŒïŒïŒïŒïŒãïŒïŒïŒïŒïŒã§ããžã¡ã
ã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ãããµã€ããã
ã³ãšã¿ããŒã«ãããªã矀ããéžã°ãã極æ§ææ©
溶åªäžãçŽ50âã110âã®æž©åºŠã§ãäžæŽ»æ§ç¡æ¹¿
æ°é°å²æ°äžã«åå¿ããããã ãããªãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã«ããæ¹æ³ã ïŒ å·¥çš(a)ã§çšãã溶åªããã¡ãã¬ã³ã¯ãã©ã€
ãããšãã¬ã³ã¯ãã©ã€ãããžã¯ãããšã¿ã³ããã«
ãšã³ããã³ãŒã³ããã³ãã·ã¬ã³ãããªã矀ããéž
ã°ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«ããæ¹æ³ã ïŒïŒ 溶åªããã³ãŒã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã«ããæ¹æ³ã ïŒïŒ å·¥çš(c)ã®åå¿ããçé žã«ãªãŠã ããã³çé ž
ãããªãŠã ãããªã矀ããéžã°ããé žææå€ãå«
æãããšãŒãã«ããã³ã¯ãããã«ã ãããªã矀ã
ãéžã°ããææ©æº¶åªäžã§è¡ãªãããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ã«ããæ¹æ³ã ïŒïŒ å·¥çš(d)ã§çšããããé±é žãå¡©é žã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«ããæ¹æ³ã ïŒïŒ å·¥çš(e)ã§çšãããã極æ§ææ©æº¶åªããžã¡ã
ã«ãã«ã ã¢ããã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«ã
ãæ¹æ³ã ïŒïŒ äžèšå·¥çšã (a) ååç©ïŒïŒïŒâãžããããâïŒâã¡ããã·â
17âã¡ãã«ã¢ã«ãã€ãã³âïŒâãªã³ããããã²
ã³åçåæ°ŽçŽ åã¯è³éŠæçåæ°ŽçŽ æº¶åªäžã§ããª
ããŠã ãžãšãã«é åã³ãªããŠã ãžâïœâããã
ã«é ãããªã矀ããéžã°ãããªããŠã ãžææ©é
è©Šè¬ãšå ±åœ¹ïŒïŒïŒä»å åå¿ã«ããåå¿ãããã (b) ãã®åå¿æ··åç©ãã¢ã³ã¢ããŠã ååç©ã®æ°Žæº¶
液ãšéããã«åå¿ãããåé¢ãããšäžèšæ§é
åŒã åŒäžãR5ã¯ãšãã«åã¯ïœâãããã«åºã§ã
ãã ãæããïŒâã¢ã«ãã«åçæç©ã補é ãã (c) ãã®ïŒâã¢ã«ãã«åçæç©ãææ©æº¶åªäžã§ã·
ã¢ãã²ã³ãã©ã€ããšåå¿ããããŠãåé¢ãããš
äžèšæ§é åŒã åŒäžãR5ã®å®çŸ©ã¯äžèšã«åãã§ããã ãæããïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ã補
é ãã (d) ãã®ïŒâã¢ã«ãã«å17âã·ã¢ãçæç©ãé±é ž
ã§å æ°Žå解ããŠãåé¢ãããšäžèšæ§é åŒã åŒäžãR5ã®å®çŸ©ã¯äžèšã«åãã§ããã ãæããïŒâã¢ã«ãã«å17âãã«çæç©ã補é
ãã (e) ãã®ïŒâã¢ã«ãã«å17âãã«çæç©ããã¢ã«
ãã«åå€ãšããŠã®ã·ã¯ãããã«ã¡ãã«ãããã€
ããšæ¥µæ§ææ©æº¶åªäžãé žææå€ã®ååšäžã§åå¿
ããããŠãææã®çæç©ã補é ãããããŠã該
çæç©ããéæµæž©åºŠã§ãå æ°Žå解å€ã«ããâ
è±ã¡ãã«åããããããŠãåå¿çæç©ãé žä»å
å¡©ãšããŠåé¢ããããšãç¹åŸŽãšããäžèšæ§é
åŒã åŒäžãR2ã¯ã·ã¯ãããã«ã¡ãã«åºã§ããã R3ã¯ããšãã«åã¯ïœâãããã«åºã§ããã ãæããååç©ã®è£œé æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87663978A | 1978-02-10 | 1978-02-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54117481A JPS54117481A (en) | 1979-09-12 |
| JPS62907B2 true JPS62907B2 (ja) | 1987-01-10 |
Family
ID=25368236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1288379A Granted JPS54117481A (en) | 1978-02-10 | 1979-02-08 | 8 betaaalkyl substituted morphinanee66one compound*its manufacture and analgesic remedy thereby |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4230712A (ja) |
| JP (1) | JPS54117481A (ja) |
| AU (1) | AU511617B2 (ja) |
| CA (1) | CA1093070A (ja) |
| DE (1) | DE2900644C2 (ja) |
| FR (2) | FR2422640A1 (ja) |
| GB (1) | GB2014142B (ja) |
| IL (1) | IL56245A (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4272541A (en) * | 1978-06-02 | 1981-06-09 | Miles Laboratories, Inc. | 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them |
| US4272540A (en) * | 1979-04-24 | 1981-06-09 | Sisa, Incorporated | 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them |
| CA1135692A (en) * | 1979-05-21 | 1982-11-16 | Michael P. Kotick | 7-methyl and 7-methyl-8-lower alkyl b/c cis or trans morphinan-6-one compounds |
| JPS5663963A (en) * | 1979-10-17 | 1981-05-30 | Miles Lab | 66methyleneemorphinan compound |
| US4370333A (en) * | 1981-06-29 | 1983-01-25 | Sisa, Incorporated | 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it |
| US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US7923454B2 (en) * | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| EP2987788A1 (en) | 2002-05-17 | 2016-02-24 | Taiwanj Pharmaceuticals Co., Ltd. | Opioid and opioid-like compounds and uses thereof |
| US8017622B2 (en) * | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| EP2931725B1 (en) | 2012-12-14 | 2017-02-15 | Purdue Pharma LP | Nitrogen containing morphinan derivatives and the use thereof |
| ES2653265T3 (es) | 2012-12-28 | 2018-02-06 | Purdue Pharma Lp | Morfinanos sustituidos y el uso de éstos |
| EP3154972A4 (en) | 2014-06-13 | 2017-11-22 | Purdue Pharma L.P. | Azamophinan derivatives and use thereof |
| WO2018125716A1 (en) | 2017-01-02 | 2018-07-05 | Purdue Pharma L.P. | Morphinan derivatives and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3211738A (en) * | 1965-10-12 | Cghso cghso cghso | ||
| US2766245A (en) * | 1956-10-09 | dehydroisomorphinanes intermedi- | ||
| US2178010A (en) * | 1937-02-03 | 1939-10-31 | Small Lyndon Frederick | Nuclear substituted derivatives of the morphine series and methods for their preparation |
| US3285922A (en) * | 1962-01-26 | 1966-11-15 | Research Corp | N-cyclopropylmethyl-and -cyclobutyl-methyl-morphinans |
| US3300500A (en) * | 1962-04-09 | 1967-01-24 | Alkylmorphinan derivatives and production thereof | |
| FR1355143A (fr) * | 1963-04-05 | 1964-03-13 | Shionogi & Co | Dérivés du morphinane et procédé de fabrication |
| US3654280A (en) * | 1968-03-21 | 1972-04-04 | Shionogi & Co | L-n allylic-3-hydroxy-6-oxomorphinans |
-
1978
- 1978-12-12 CA CA317,750A patent/CA1093070A/en not_active Expired
- 1978-12-18 IL IL56245A patent/IL56245A/xx unknown
-
1979
- 1979-01-09 DE DE2900644A patent/DE2900644C2/de not_active Expired
- 1979-01-25 FR FR7901967A patent/FR2422640A1/fr active Granted
- 1979-02-06 GB GB7904030A patent/GB2014142B/en not_active Expired
- 1979-02-08 AU AU44089/79A patent/AU511617B2/en not_active Ceased
- 1979-02-08 JP JP1288379A patent/JPS54117481A/ja active Granted
- 1979-05-21 US US06/040,664 patent/US4230712A/en not_active Expired - Lifetime
- 1979-10-04 FR FR7924720A patent/FR2430420A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2900644A1 (de) | 1979-08-16 |
| GB2014142A (en) | 1979-08-22 |
| FR2422640A1 (fr) | 1979-11-09 |
| US4230712A (en) | 1980-10-28 |
| IL56245A0 (en) | 1979-03-12 |
| FR2430420A1 (fr) | 1980-02-01 |
| JPS54117481A (en) | 1979-09-12 |
| AU511617B2 (en) | 1980-08-28 |
| FR2430420B1 (ja) | 1982-03-12 |
| DE2900644C2 (de) | 1982-07-08 |
| GB2014142B (en) | 1982-08-04 |
| FR2422640B1 (ja) | 1983-02-25 |
| IL56245A (en) | 1981-09-13 |
| CA1093070A (en) | 1981-01-06 |
| AU4408979A (en) | 1979-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4272541A (en) | 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them | |
| JP3447292B2 (ja) | ã€ãããŸããªãžã³åã³èè žã®çŸç ã®æ²»çã®ããã®ãã®äœ¿çš | |
| EP1994034B1 (en) | Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds | |
| JPS62907B2 (ja) | ||
| AU2003290630A1 (en) | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts | |
| CN102459275A (zh) | å¶å€åå¡ç·ååå¡é ®ååç©çæ¹æ³ | |
| JPH0112755B2 (ja) | ||
| JPS61271275A (ja) | ã¢ã«ããã³èªå°äœ | |
| AU642447B2 (en) | Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via N-nor intermediates | |
| US4272540A (en) | 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them | |
| US3318885A (en) | Substituted 6-amino-6, 14-endoethen-ocodides and morphides | |
| US4241065A (en) | Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both | |
| US4275205A (en) | 7,7-Ditosyloxymethyl-4,5α-epoxy-morphinan-6-ols | |
| HK24194A (en) | Pyrrolo[1,2-a][4,1]benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use | |
| FI81583B (fi) | Foerfarande foer n-demetylering av morfinanalkaloider. | |
| DE3873786T2 (de) | Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-essigsaeuren. | |
| CN100379741C (zh) | å¶å€å£n-ç·åºåå¡åçç©ç¢±ççæ¹æ³ | |
| EP0019254B1 (en) | 7-methyl and 7-methyl-8-lower alkyl b/c cis or trans morphinan-6-one compounds, process for their preparation and pharmaceutical preparations containing them | |
| US3488354A (en) | Substituted 7,8 - dihydro - 6-hydroxy-6,14-endo (etheno or ethano)codide - 7-ketones and substituted 7,8 - dihydro-6-hydroxy-6,14-endo (etheno or ethano) morphide-7-ketones | |
| RU2236412C2 (ru) | СпПÑПб пПлÑÑÐµÐœÐžÑ Ð¿ÑПОзвПЎМÑÑ ÐŒÐŸÑÑОМПМа, ÑпПÑПб пПлÑÑÐµÐœÐžÑ Ð¿ÑПОзвПЎМÑÑ 14-гОЎÑПкÑОЌПÑÑОМПМа, О ÑпПÑПб пПлÑÑÐµÐœÐžÑ Ð¿ÑПОзвПЎМÑÑ ÐŸÐºÑОЌПÑÑПМа | |
| JPS6212221B2 (ja) | ||
| EP0009227B1 (en) | Fluorination process and fluoro analogs of hydrocodone and oxycodone | |
| US4440931A (en) | 7β-Arylalkyl-3-methoxy or 3-hydroxy-4,5α-epoxy-6β-hydroxy-7α-hydroxymethyl-17-methyl or 17-cycloalkylmethylmorphinans | |
| Allen | Synthesis of new codeinone and indolinocodeinone derivatives | |
| EP2344508A1 (en) | Processes for the synthesis of opiate alkaloids with reduced impurity formation |